<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Unipolar depression in adults: Indications, efficacy, and safety of transcranial magnetic stimulation (TMS)</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Unipolar depression in adults: Indications, efficacy, and safety of transcranial magnetic stimulation (TMS)</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Unipolar depression in adults: Indications, efficacy, and safety of transcranial magnetic stimulation (TMS)</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Paul E Holtzheimer, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Peter P Roy-Byrne, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David Solomon, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Feb 15, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H31837777"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Many patients with unipolar major depression do not respond to standard treatment with pharmacotherapy and psychotherapy [<a href="#rid1">1,2</a>], and are thus candidates for noninvasive neuromodulation procedures such as repetitive transcranial magnetic stimulation (TMS) and electroconvulsive therapy (ECT) [<a href="#rid3">3-5</a>]. Although ECT is more efficacious than repetitive TMS [<a href="#rid6">6,7</a>], patients may prefer repetitive TMS because it is better tolerated and unlike ECT, TMS does not require general anesthesia and induction of seizures.</p><p>Following the invention of modern TMS in 1985, the US Food and Drug Administration approved it for treatment-resistant depression in 2008 [<a href="#rid8">8</a>]. Other neuropsychiatric disorders that have been treated with TMS include bipolar disorder, depersonalization/derealization disorder, generalized anxiety disorder, obsessive-compulsive disorder, chronic pain, Parkinson disease, posttraumatic stress disorder, schizophrenia, smoking cessation, stroke rehabilitation, and tinnitus [<a href="#rid8">8-19</a>].</p><p>This topic reviews the indications, efficacy, and safety of repetitive TMS for treating unipolar major depression in adults; the administration of TMS is reviewed elsewhere. Other neuromodulation procedures, including ECT, vagus nerve stimulation, and deep brain stimulation are also discussed separately, as is choosing treatment for resistant depression:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/113603.html" rel="external">"Unipolar major depression: Administering transcranial magnetic stimulation (TMS)"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/16519.html" rel="external">"Unipolar depression in adults: Overview of neuromodulation procedures"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/1709.html" rel="external">"Overview of electroconvulsive therapy (ECT) for adults"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/16518.html" rel="external">"Unipolar depression in adults: Treatment with surgical approaches"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/14685.html" rel="external">"Unipolar depression in adults: Choosing treatment for resistant depression"</a>.)</p><p></p><p class="headingAnchor" id="H31837784"><span class="h1">OVERVIEW</span><span class="headingEndMark"> — </span>Repetitive transcranial magnetic stimulation (TMS) treats major depression by modulating activity in cortical regions and associated neural circuits [<a href="#rid20">20</a>]. The intervention uses a large alternating electrical current passed through a metal coil placed against the scalp to generate rapidly alternating magnetic fields, which pass through the skull nearly unimpeded and induce electric currents that depolarize neurons in a focal area of the surface cortex; some TMS devices may also stimulate deeper brain structures [<a href="#rid8">8,21-23</a>]. The magnetic field generated by TMS is comparable to that of a standard magnetic resonance imaging (MRI) device (approximately 1.5 to 3 Tesla); however, the TMS field is focal (beneath the coil), whereas the MRI field is large and fills the room housing the MRI device [<a href="#rid22">22,24</a>].</p><p>In addition to its use as a therapeutic tool, TMS has been used in attempts to map brain functions and connections between different brain regions, and assess cortical excitability and brain-behavior relationships [<a href="#rid20">20,25</a>]. TMS has also been studied as a diagnostic tool [<a href="#rid26">26</a>].</p><p>The US Food and Drug Administration has approved repetitive TMS devices that can administer different types of stimulation, including:</p><p class="bulletIndent1"><span class="glyph">●</span>Surface cortical stimulation</p><p class="bulletIndent2"><span class="glyph">•</span>High frequency</p><p class="bulletIndent2"><span class="glyph">•</span>Low frequency</p><p class="bulletIndent1"><span class="glyph">●</span>Theta burst stimulation</p><p class="bulletIndent1"><span class="glyph">●</span>Deep stimulation</p><p></p><p>Administering these standard types of TMS is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/113603.html" rel="external">"Unipolar major depression: Administering transcranial magnetic stimulation (TMS)"</a>.)</p><p class="headingAnchor" id="H174821090"><span class="h2">Mechanism of action</span><span class="headingEndMark"> — </span>The mechanism of action of repetitive TMS is unknown. One hypothesis is that stimulation of discrete cortical regions alters pathologic activity within a network of grey matter brain regions that are involved in mood regulation and connected to the targeted cortical sites [<a href="#rid27">27,28</a>]. This is supported by functional imaging studies that show TMS can change activity in brain regions remote from the site of stimulation [<a href="#rid29">29-44</a>]. As an example, functional MRI indicates that surface cortical stimulation of the left dorsal lateral prefrontal cortex increases anterior cingulate cortex connectivity within a meso-cortico-limbic network that may be involved in mood and includes the dorsal cingulate cortex, posterior dorso-medial prefrontal cortex, dorsal lateral prefrontal cortex, inferior parietal lobule, inferior frontal cortex, and posterior temporal lobes [<a href="#rid45">45</a>]. In addition, stimulation of the left dorsal lateral prefrontal cortex with either surface cortical TMS or theta burst TMS may decrease functional connectivity between the default mode network and the anterior cingulate cortex [<a href="#rid46">46</a>].</p><p>Repetitive TMS may also act by stimulating neuroplasticity. This may lead to increased expression of brain-derived neurotrophic factor and to structural changes, such as increased hippocampal volume [<a href="#rid47">47,48</a>].</p><p>Some molecular effects of repetitive TMS are comparable to those of ECT, including increased monoamine turnover and normalization of the hypothalamic pituitary axis [<a href="#rid24">24</a>]. In one neuroimaging study of depressed patients, a prefrontal serotonin deficiency at baseline normalized after treatment with TMS [<a href="#rid24">24</a>].</p><p>The effect of repetitive TMS appears to vary according to the frequency. High frequency surface cortical stimulation is thought to excite the targeted neurons (and is typically used to activate the left prefrontal cortex), whereas low frequency surface cortical stimulation appears to inhibit cortical activity (and is usually directed at the right prefrontal cortex) [<a href="#rid28">28</a>]. Consistent with this hypothesis, multiple reviews of studies in depressed patients who were treated with TMS targeting the dorsal lateral prefrontal cortex have found that high frequency TMS generally increased regional cerebral blood flow and that low frequency TMS generally decreased regional cerebral blood flow [<a href="#rid42">42,49</a>]. In addition, a prospective observational study of 15 patients with treatment-resistant unipolar major depression, who were treated with high frequency TMS of the left dorsal lateral prefrontal cortex, found that increased cerebral blood flow in the frontal cortex was associated with clinical improvement [<a href="#rid50">50</a>].</p><p class="headingAnchor" id="H2497412"><span class="h1">INDICATIONS</span><span class="headingEndMark"> — </span>The role of repetitive transcranial magnetic stimulation (TMS) in choosing treatment for patients with unipolar major depression is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/14685.html" rel="external">"Unipolar depression in adults: Choosing treatment for resistant depression", section on 'Transcranial magnetic stimulation'</a>.)</p><p>Repetitive TMS is indicated for patients with unipolar major depression who have failed at least one antidepressant medication; in some studies, patients have failed multiple courses of pharmacotherapy and psychotherapy as well as a trial of electroconvulsive therapy [<a href="#rid51">51</a>], and most patients have suffered prior episodes of major depression [<a href="#rid22">22</a>]. In addition, TMS is indicated for patients who responded to a prior course of TMS [<a href="#rid22">22</a>]. TMS may also help depressed patients with general medical comorbidities because the treatment does not cause systemic adverse effects [<a href="#rid8">8</a>]. (See <a class="local">'Safety and adverse effects'</a> below.)</p><p>Use of repetitive TMS for treatment-resistant depression is consistent with treatment guidelines from the American Psychiatric Association [<a href="#rid3">3,5</a>], Canadian Network for Mood and Anxiety Treatments [<a href="#rid4">4</a>], British Association for Psychopharmacology [<a href="#rid52">52</a>], and the Royal Australian and New Zealand College of Psychiatrists [<a href="#rid53">53</a>].</p><p>Relatively few patients with unipolar major depression who are medication-naïve have been treated with TMS in a clinical trial [<a href="#rid54">54</a>]. Nevertheless, using TMS is reasonable as first-line treatment if patients decline pharmacotherapy and cannot access psychotherapy, such as patients who are pregnant or breastfeeding, have contraindications such as pre-existing liver damage, or are adolescents.</p><p class="headingAnchor" id="H478350592"><span class="h1">CONTRAINDICATIONS</span><span class="headingEndMark"> — </span>To screen patients for contraindications to repetitive transcranial magnetic stimulation (TMS), we use a 13-item, clinician-administered questionnaire  (<a class="graphic graphic_table graphicRef85964" href="/z/d/graphic/85964.html" rel="external">table 1</a>) [<a href="#rid55">55</a>].</p><p>Repetitive TMS is contraindicated in patients with [<a href="#rid16">16,56-58</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Increased risks for seizures (see <a class="local">'Seizure'</a> below)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Implanted metallic hardware, such as clips, electrodes, plates, and stimulators (eg, deep brain stimulators and vagus nerve stimulators)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Metal fragments (eg, bullets)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cochlear implants</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Implanted electrical devices, including cardiac pacemakers, implantable cardioverter-defibrillators, intracardiac lines, and medication pumps</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tattoos in the head or neck made with ferromagnetic-containing ink</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Unstable general medical disorders</p><p></p><p>Conversely, TMS is safe in patients with nonferromagnetic orthodontic hardware (eg, braces and fillings) and metal implants below the neck [<a href="#rid16">16</a>].</p><p>It may be possible to safely use repetitive TMS in depressed patients with a personal or family history of seizures if the stimulation frequency is low (≤1 pulse per second) and the motor threshold is monitored to ensure that stimulation intensity does not exceed the recommended safety range [<a href="#rid59">59</a>]. However, patients at increased risk for seizures should be considered for repetitive TMS only if the potential benefit outweighs the increased risk; as an example, the depressive episode has not responded to adequate pharmacotherapy, including monotherapy and combination treatment, as well as trials of psychotherapy and electroconvulsive therapy (ECT). Stimulation frequency and choosing treatment for resistant depression are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/113603.html" rel="external">"Unipolar major depression: Administering transcranial magnetic stimulation (TMS)", section on 'Treatment parameters'</a> and  <a class="medical medical_review" href="/z/d/html/14685.html" rel="external">"Unipolar depression in adults: Choosing treatment for resistant depression"</a>.)</p><p>In addition, the contraindication to repetitive TMS in patients with an implanted vagus nerve stimulator is not absolute, provided that the TMS coil is not positioned near the vagus nerve stimulator components [<a href="#rid16">16,60</a>]. Prior to administering TMS to these patients, we suggest consultation with experts in using vagus nerve stimulation.</p><p>Psychotic features (eg, delusions and hallucinations) are not a contraindication for treating major depression with repetitive TMS [<a href="#rid61">61</a>], but most randomized trials have excluded psychotic patients [<a href="#rid16">16,56,62-66</a>]. In addition, one practice guideline on using TMS suggested treating psychotic depression with remedies other than TMS, such as ECT [<a href="#rid16">16</a>]. The clinical features and treatment of psychotic depression are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/14686.html" rel="external">"Unipolar major depression with psychotic features: Epidemiology, clinical features, assessment, and diagnosis", section on 'Clinical features'</a> and  <a class="medical medical_review" href="/z/d/html/16546.html" rel="external">"Unipolar major depression with psychotic features: Acute treatment"</a>.)</p><p class="headingAnchor" id="H31837791"><span class="h1">EFFICACY</span><span class="headingEndMark"> — </span>Based upon randomized trials, multiple reviews have consistently concluded that repetitive transcranial magnetic stimulation (TMS) can be efficacious and is generally safe for patients with treatment-resistant unipolar major depression [<a href="#rid8">8,16,22,23</a>]. More randomized trials have examined the efficacy of surface cortical TMS compared with other standard TMS protocols, such as deep TMS and theta burst TMS [<a href="#rid67">67</a>]. Although it is feasible to blind/mask clinicians administering TMS as well as patients and outcome raters [<a href="#rid20">20</a>], a methodologic limitation of many trials is that clinicians administering TMS were not blinded.</p><p>Evidence supporting the use of repetitive TMS includes a network meta-analysis of 31 randomized trials of pharmacologic and somatic interventions in patients with treatment-resistant depression (sample size not reported), including 11 trials that studied TMS [<a href="#rid68">68</a>]. Six weeks after baseline, response (improvement of symptoms ≥50 percent) was more than eight times as likely with TMS than placebo pill/sham stimulation (odds ratio 8.6, 95% CI 1.2-112.6). However, discontinuation of treatment due to adverse effects was four times more likely with TMS than placebo pill/sham.</p><p>Although the relative efficacy and acceptability of different repetitive TMS protocols is not clear because few head-to-head trials have been conducted, it appears that outcomes with surface cortical TMS, theta burst TMS, and deep TMS are generally comparable. Two separate network meta-analyses compared different TMS protocols, including surface cortical TMS, theta burst TMS, and deep TMS, as well as experimental modalities such as an accelerated TMS and bilateral TMS, using results from direct comparisons between the modalities, as well as indirectly comparing modalities through their relative effect with a common comparator (eg, sham stimulation) [<a href="#rid67">67,69</a>]. Each study found that response and all-cause discontinuation were comparable among surface cortical TMS, theta burst TMS, and deep TMS.</p><p>Results of head-to-head comparisons between standard TMS protocols are described elsewhere in this topic. (See <a class="local">'Theta burst TMS'</a> below and <a class="local">'Deep TMS'</a> below.)</p><p class="headingAnchor" id="H850689378"><span class="h2">Surface cortical TMS</span><span class="headingEndMark"> — </span>Repetitive TMS that stimulates the surface cortex is called surface cortical TMS; this is the most widely used and studied form of TMS. The administration of surface cortical TMS is described separately. (See  <a class="medical medical_review" href="/z/d/html/113603.html" rel="external">"Unipolar major depression: Administering transcranial magnetic stimulation (TMS)", section on 'Surface cortical TMS'</a>.)</p><p class="headingAnchor" id="H259860039"><span class="h3">Acute treatment</span><span class="headingEndMark"> — </span>For patients with acute major depression who have not responded to at least one antidepressant medication, numerous meta-analyses of randomized trials have demonstrated that repetitive surface cortical TMS is superior to sham treatment [<a href="#rid67">67,70-77</a>]. However, the best evidence indicates that TMS is less effective than electroconvulsive therapy (ECT). (See  <a class="medical medical_review" href="/z/d/html/1711.html" rel="external">"Unipolar major depression in adults: Indications for and efficacy of electroconvulsive therapy (ECT)"</a>.)</p><p class="headingAnchor" id="H2613176"><span class="h4">Compared with sham treatment (placebo)</span><span class="headingEndMark"> — </span>Multiple randomized trials have consistently demonstrated that repetitive surface cortical TMS is superior to sham TMS for treatment-resistant unipolar major depression [<a href="#rid70">70-72,74,78,79</a>]. These trials indicate that high frequency surface cortical TMS over the left dorsolateral prefrontal cortex (high frequency left TMS) and low frequency surface cortical TMS over the right dorsolateral prefrontal cortex (low frequency right TMS) are each efficacious and well tolerated. As an example, over 40 trials show that response (reduction of baseline symptoms ≥50 percent) is at least three times more likely with high frequency left TMS than sham TMS. Also, all-cause discontinuation of treatment with high frequency left TMS and low frequency right TMS is comparable to that of sham TMS:</p><p class="bulletIndent1"><span class="glyph">●</span>A systematic review conducted meta-analyses that found high frequency left TMS and low frequency right TMS were each superior to sham TMS [<a href="#rid67">67</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>One meta-analysis (50 trials, sample size not reported) found that response was more than three times as likely with high frequency left TMS than sham TMS (odds ratio 3.3, 95% CI 2.3-4.6).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A second meta-analysis (12 trials, sample size not reported) found that response was more than twice as likely with low frequency right TMS than sham TMS (odds ratio 2.5, 95% CI 1.2-5.1).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A subsequent systematic review also found that high frequency left TMS and low frequency right TMS were each superior to sham TMS [<a href="#rid69">69</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A meta-analysis of 43 trials compared high frequency left TMS with sham TMS in 1907 patients with treatment-resistant depression. Response was more likely to occur with active TMS (odds ratio 3.5, 95% CI 2.4-5.2).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A second meta-analysis of seven trials compared low frequency right TMS with sham TMS in 234 patients with treatment-resistant depression. Response was more likely to occur with active TMS (odds ratio 3.7, 95% CI 1.3-10.3).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>All-cause discontinuation of treatment in the four meta-analyses was comparable for active and sham treatment.</p><p></p><p>However, absolute rates of remission with repetitive TMS in some studies are modest [<a href="#rid80">80</a>]. As an example, two relatively large and rigorous randomized trials (n = 301 and 190) both found that remission with active high frequency left TMS occurred in only 14 percent of patients (compared with 5 to 6 percent in the sham TMS groups) [<a href="#rid20">20,56</a>]. One explanation is that some trials required patients to be medication free and to discontinue antidepressants that may have been partially effective. In addition, the low absolute rates of remission are consistent with findings that depressed patients who have previously failed pharmacotherapy are generally less responsive to subsequent pharmacotherapy or ECT [<a href="#rid16">16,56</a>].</p><p class="headingAnchor" id="H2643996983"><span class="h5">Combined with pharmacotherapy</span><span class="headingEndMark"> — </span>Repetitive TMS for unipolar major depression is typically administered in conjunction with antidepressants [<a href="#rid8">8</a>]. In most randomized trials that compared active TMS with sham TMS, the experimental procedure was added onto antidepressant medications that were ineffective for the presenting episodes, but were nevertheless maintained during the trials so that all patients received active treatment. As an example, in a meta-analysis of 34 trials that found active TMS was superior to sham treatment, patients were free of antidepressant medications in only seven trials [<a href="#rid74">74</a>].</p><p>For patients who have not responded to adequate antidepressant therapy, add-on treatment with repetitive TMS is efficacious. A pooled analysis of six randomized trials compared active TMS with sham TMS as augmentation in patients (n = 230) with treatment-resistant depression who continued their antidepressant drugs [<a href="#rid81">81</a>]. Patients received 10 to 30 sessions of high frequency, left surface cortical TMS. Response (eg, reduction of baseline symptoms ≥50 percent) occurred in more patients who received active than sham TMS (47 versus 22 percent).</p><p>In addition, simultaneously starting repetitive TMS plus pharmacotherapy for major depression may be superior to initiating pharmacotherapy alone. A meta-analysis of four randomized trials (213 patients) compared high frequency repetitive TMS plus antidepressants (primarily selective serotonin reuptake inhibitors) with antidepressants alone as initial treatment and found that remission occurred more often with combination treatment (odds ratio 2.4, 95% CI 1.3-4.6) [<a href="#rid82">82</a>]. However, two negative studies did not report enough data for the purposes of the meta-analysis and were thus excluded [<a href="#rid65">65,83</a>].</p><p>No randomized trials have established that simultaneously starting repetitive TMS plus pharmacotherapy is superior to initiating TMS alone for major depression [<a href="#rid84">84,85</a>].</p><p class="headingAnchor" id="H2497627"><span class="h5">Predictors of response</span><span class="headingEndMark"> — </span>Randomized trials indicate that treatment protocol (type of stimulation) is not associated with the rate of response in patients treated with surface cortical repetitive TMS. One meta-analysis (34 randomized trials, 1383 depressed patients) compared left dorsal lateral prefrontal cortex TMS with right dorsal lateral prefrontal cortex stimulation and found that efficacy was comparable [<a href="#rid74">74</a>]. Other meta-analyses suggest that the benefits of high frequency (&gt;1 pulse per second) and low frequency (≤1 pulse per second) TMS are comparable [<a href="#rid67">67,70,86,87</a>].</p><p>Although individual studies of repetitive TMS for major depression have found clinical factors associated with response (eg, number of antidepressant medications that have failed to resolve the presenting episode [<a href="#rid88">88</a>]), no consistent predictors have been identified in meta-analyses. As an example, a meta-analysis of 30 randomized trials (1164 patients) found that improvement was greater with active repetitive TMS than sham treatment; however, the effect of repetitive TMS was comparable in trials with medication-resistant depression and trials with nonmedication-resistant depression [<a href="#rid86">86</a>]. In addition, a subsequent randomized trial found that the number of adequate antidepressant trials prior to onset of TMS was not associated with response [<a href="#rid89">89</a>].</p><p>Some studies have suggested that use of benzodiazepines may reduce the antidepressant effect of repetitive TMS:</p><p class="bulletIndent1"><span class="glyph">●</span>A randomized trial compared high frequency, surface cortical TMS with theta burst TMS in 388 patients with treatment-resistant unipolar major depression; TMS was added onto stable pharmacotherapy regimens, which included benzodiazepines in 32 percent of the patients [<a href="#rid89">89</a>]. Among the 388 patients, nonresponse to TMS was more than twice as likely among patients taking benzodiazepines (odds ratio 2.25, 95% CI 0.99-5.11).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A retrospective study identified patients with unipolar major depression who were treated with high frequency, surface cortical TMS of the left dorsolateral prefrontal cortex, as well as low frequency surface cortical TMS of the right dorsolateral prefrontal cortex if response to left-sided stimulation was inadequate [<a href="#rid90">90</a>]. Concomitant benzodiazepines were present in 72 patients and absent in 109 patients. Response at week 6 occurred in fewer benzodiazepine users than nonusers (16 versus 36 percent).</p><p></p><p>However, a potential confounding factor in both studies is comorbid anxiety, which may be associated with a poor response to TMS, just as it is associated with a poor response to pharmacotherapy [<a href="#rid8">8,91</a>]. Both studies measured anxiety symptoms and attempted to control for it in the analyses and the randomized trial found that anxiety did not predict response to TMS. Nevertheless, neither study was designed to specifically assess the relationship between anxiety and response to TMS, and the association between benzodiazepines and poor response may have been due to residual confounding.</p><p>One proposed predictor of response to repetitive TMS in patients with depression is comorbid posttraumatic stress disorder (PTSD). A randomized trial raised the possibility that add-on, high frequency surface cortical TMS over the left prefrontal cortex was no better than sham TMS for veterans (n = 164) with treatment-resistant unipolar major depression because nearly half of them had PTSD [<a href="#rid92">92</a>]. However, another randomized trial found that in veterans (n = 103) with a primary diagnosis of PTSD, adjunctive, low frequency right dorsal lateral prefrontal cortex stimulation was beneficial for this disorder [<a href="#rid18">18</a>]. Also, in a prospective observational study of veterans with treatment-resistant major depression who were treated with high frequency, left prefrontal TMS, remission was comparable in those without comorbid PTSD (n = 45) and those with PTSD (n = 44) [<a href="#rid93">93</a>].</p><p>Other proposed clinical predictors of response to repetitive TMS include relatively less severe episodes of unipolar treatment-resistant major depression, which may be more likely to respond [<a href="#rid89">89</a>]. By contrast, patients who initially respond poorly to TMS (eg, &lt;20 percent improvement after two weeks) may be less likely to respond with additional treatment [<a href="#rid94">94</a>].</p><p>Neurobiologic factors such as the functional connectivity of the stimulation target to neural networks involved in depression may predict response to repetitive TMS [<a href="#rid95">95-101</a>]. Genetic polymorphisms, baseline regional cerebral blood flow, and baseline resting electroencephalography measures may also be associated with response to TMS [<a href="#rid102">102</a>]. However, assessing these factors to predict response is restricted to research settings and is not part of standard clinical care.</p><p class="headingAnchor" id="H174821114"><span class="h4">Compared with electroconvulsive therapy</span><span class="headingEndMark"> — </span>For treatment of major depression, the best evidence indicates that repetitive TMS is less efficacious than electroconvulsive therapy (ECT). (See  <a class="medical medical_review" href="/z/d/html/1711.html" rel="external">"Unipolar major depression in adults: Indications for and efficacy of electroconvulsive therapy (ECT)"</a>.)</p><p class="headingAnchor" id="H259859970"><span class="h4">Durability of response</span><span class="headingEndMark"> — </span>Among patients with major depression who respond to acute treatment with repetitive TMS, the benefit of TMS is often stable in the short-term (eg, four weeks posttreatment). In addition, response to TMS may persist for at least one year:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Short-term</strong> – A meta-analysis of 16 trials included 495 patients who were randomly assigned to active TMS or sham TMS and then followed posttreatment for 1 to 16 weeks [<a href="#rid103">103</a>]. TMS consisted of high frequency stimulation of the left dorsolateral prefrontal cortex; the trials included relatively few sessions (5 to 15) and utilized low dosing parameters (eg, 800 to 2000 stimuli per session) compared with standard protocols. Follow-up in most trials lasted one to four weeks; during follow-up, none of the trials administered maintenance TMS, but most patients received antidepressant medications. Depression rating scale scores during follow-up were lower in patients who received active TMS than sham TMS and the clinical advantage was moderate.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Longer-term</strong> – A subsequent meta-analysis examined durability of response in 732 patients who responded to acute treatment with TMS in randomized trials or observational studies and were followed posttreatment for a minimum of three months [<a href="#rid104">104</a>]. During follow-up, patients received maintenance treatment with TMS and/or pharmacotherapy. Among the initial responders, the proportion who sustained response at different time points posttreatment was as follows:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>3 months – 67 percent</p><p class="bulletIndent2"><span class="glyph">•</span>6 months – 53 percent</p><p class="bulletIndent2"><span class="glyph">•</span>12 months – 46 percent</p><p></p><p>Across different studies, there are no clinical factors that are consistently associated with a durable response to TMS [<a href="#rid103">103,104</a>].</p><p class="headingAnchor" id="H967400818"><span class="h4">Following relapse</span><span class="headingEndMark"> — </span>For patients with unipolar major depression who improve with a course of repetitive TMS and subsequently deteriorate or relapse, observational data suggest that another course (reintroduction) of TMS using the same stimulation parameters may be helpful [<a href="#rid22">22,105-112</a>].</p><p class="headingAnchor" id="H1858533306"><span class="h3">Maintenance TMS</span><span class="headingEndMark"> — </span>Among patients with unipolar major depression who respond to acute repetitive TMS, it is not known if maintenance TMS for is beneficial. Although two randomized trials found that maintenance TMS was not beneficial, both studies were limited by small samples and the frequency of maintenance treatment in these trials may have been inadequate:</p><p class="bulletIndent1"><span class="glyph">●</span>A 12-month, open label trial, which included 49 medication free patients who initially responded to acute TMS (Hamilton Rating Scale for Depression  (<a class="graphic graphic_table graphicRef72220" href="/z/d/graphic/72220.html" rel="external">table 2</a>) score &lt;15), found that administering maintenance TMS only once per month provided no advantage over watchful waiting [<a href="#rid112">112</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>An 11-month trial compared active maintenance TMS plus pharmacotherapy with sham maintenance TMS plus pharmacotherapy in 17 patients who initially responded to acute TMS plus pharmacotherapy; response was defined as at least 50 percent reduction of baseline scores on the Hamilton Rating Scale for Depression [<a href="#rid113">113</a>]. Maintenance TMS was delivered by gradually tapering treatment over a three-month period from daily sessions to one session every two weeks. The benefit of active and sham maintenance TMS was comparable.</p><p></p><p>However, in several small observational studies of patients who responded (eg, reduction of baseline symptoms ≥50 percent) to acute TMS, the results suggest that maintenance TMS may be beneficial [<a href="#rid59">59,114-116</a>].</p><p>In addition, there is evidence that maintenance TMS may be effective in acutely depressed patients who improve after treatment with antidepressant medications. In one study, patients (n = 281) with depressive syndromes who responded to open label antidepressants for at least three months were randomly assigned to one of three treatment regimens for one year: continue the same antidepressant as monotherapy, continue the same antidepressant and add TMS, or switch to TMS as monotherapy [<a href="#rid117">117</a>]. Relapse occurred in fewer patients who received either antidepressant plus TMS or TMS alone, compared with antidepressant alone (16 and 24 versus 44 percent). The difference between antidepressant plus TMS and TMS alone was not statistically significant.</p><p class="headingAnchor" id="H4127331969"><span class="h2">Theta burst TMS</span><span class="headingEndMark"> — </span>Theta burst (or intermittent theta burst) repetitive TMS involves high frequency magnetic pulses that are administered at 50 hertz five times per second and are intended to mimic endogenous theta rhythms. (See  <a class="medical medical_review" href="/z/d/html/113603.html" rel="external">"Unipolar major depression: Administering transcranial magnetic stimulation (TMS)", section on 'Theta burst TMS'</a>.)</p><p>Randomized trials that compared theta burst TMS with sham TMS for unipolar major depression demonstrate that theta burst TMS is efficacious and well tolerated [<a href="#rid78">78,79</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>In a systematic review, a conventional meta-analysis used direct evidence from four randomized trials in 155 patients with major depression and found that response (reduction of baseline symptoms ≥50 percent) was more likely to occur with theta burst TMS than sham TMS (odds ratio 2.6, 95% CI 1.2-5.6) [<a href="#rid67">67</a>]. In addition, the review included a network meta-analysis that used both direct and indirect evidence; the network meta-analysis also showed that theta burst TMS was more efficacious than sham TMS. In both meta-analyses, discontinuation of treatment for any reason was comparable for active and sham treatment.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A pooled analysis of five randomized trials compared theta burst TMS with sham TMS in patients with major depression (n = 221) and found that response occurred in more patients who received active treatment (36 versus 17 percent) [<a href="#rid118">118</a>]. In addition, discontinuation of treatment for any reason was comparable for active and sham theta burst TMS (4 and 8 percent).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A meta-analysis of three randomized trials compared theta burst TMS with sham TMS in 89 patients with treatment-resistant depression [<a href="#rid69">69</a>]. Response was more likely to occur with theta burst TMS (odds ratio 4.3, 95% CI 1.2-14.8).</p><p></p><p>In addition, randomized trials indicate that the efficacy and acceptability of theta burst TMS are comparable to that of surface cortical TMS and deep TMS:</p><p class="bulletIndent1"><span class="glyph">●</span>In network meta-analyses, response and all-cause discontinuation of theta burst TMS were comparable to that of surface cortical TMS and deep TMS. (See <a class="local">'Efficacy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A four-week, noninferiority randomized trial compared add-on theta burst TMS with surface cortical TMS in 414 patients with unipolar major depression that did not respond to an antidepressant [<a href="#rid119">119</a>]. With theta burst TMS, 600 pulses per session were delivered over three minutes; with surface cortical TMS, 3000 pulses per session were delivered over 37.5 minutes. All patients received up to 30 daily sessions. Both treatments targeted the left dorsolateral prefrontal cortex with a stimulus intensity of 120 percent of resting motor threshold. The trial was open-label, but outcome assessors were masked to treatment. The completer analysis showed that remission with theta burst and conventional TMS was comparable (32 and 27 percent). The most common adverse event was headache, which occurred in approximately 65 percent of patients in each group. Although average pain scores were modestly greater with theta burst TMS, all-cause discontinuation of treatment in each group was comparable (approximately 7 percent).</p><p></p><p class="headingAnchor" id="H3443475199"><span class="h2">Deep TMS</span><span class="headingEndMark"> — </span>Commercially available repetitive TMS devices have been developed that theoretically stimulate brain structures beneath the superficial prefrontal cortex using magnetic coils (H coils). (See  <a class="medical medical_review" href="/z/d/html/113603.html" rel="external">"Unipolar major depression: Administering transcranial magnetic stimulation (TMS)", section on 'Deep TMS'</a>.)</p><p>Several studies suggest that deep repetitive TMS is safe and beneficial for unipolar major depression [<a href="#rid22">22,120,121</a>]. As an example, a 16-week randomized trial compared deep TMS with sham TMS in 212 patients with treatment-resistant depression who discontinued all medications [<a href="#rid122">122</a>]. During the first four weeks of the trial, study treatments were administered each weekday and during the next 12 weeks, two days per week. Response (reduction of baseline symptoms ≥50 percent) occurred in more patients who received active TMS than sham TMS:</p><p class="bulletIndent1"><span class="glyph">●</span>After 4 weeks – 37 versus 28 percent</p><p class="bulletIndent1"><span class="glyph">●</span>After 16 weeks – 41 versus 26 percent</p><p></p><p>Application site pain occurred in more patients with active TMS than sham TMS (5 versus 0 percent). Other adverse effects such as headache were comparable for the two groups.</p><p>Based upon network meta-analyses of randomized trials, the efficacy and acceptability of deep TMS appears to be comparable to that of surface cortical TMS and theta burst TMS (see <a class="local">'Efficacy'</a> above). Nevertheless, other evidence suggests that deep TMS may perhaps be more efficacious than surface cortical TMS. Subsequent to the network meta-analyses, a four-week randomized trial compared add-on deep TMS (20 sessions) with surface cortical TMS in patients with treatment-resistant depression (n = 147) who continued to receive stable, ongoing pharmacotherapy [<a href="#rid123">123</a>]. Although remission in the two groups was comparable, response occurred in more patients who were treated with adjunctive deep TMS than surface cortical TMS (67 versus 44 percent). In addition, all-cause discontinuation occurred more than twice as often with deep TMS than surface cortical TMS (10 and 4 percent of patients). Adverse effects with deep TMS and surface cortical TMS included the following: headache (29 and 20 percent of patients), muscle twitching/spasms or jaw pain (12 and 0 percent), and application site pain (7 and 0 percent).</p><p class="headingAnchor" id="H31837798"><span class="h1">SAFETY AND ADVERSE EFFECTS</span><span class="headingEndMark"> — </span>Repetitive transcranial magnetic stimulation (TMS) is generally safe and well-tolerated [<a href="#rid16">16,20,22,24,56</a>] and does not cause systemic side effects [<a href="#rid8">8</a>]. As an example, a randomized trial in 301 patients found that study discontinuation due to adverse effects was comparable for active and sham surface cortical repetitive TMS (5 and 3 percent) [<a href="#rid56">56</a>]. Among the standard types of TMS stimulation (surface cortical, theta burst, and deep), it is not clear if there are clinically significant differences in the safety and adverse effects because relatively few head-to-head trials have been conducted.</p><p class="headingAnchor" id="H2191408983"><span class="h2">Seizure</span><span class="headingEndMark"> — </span>The most serious adverse effect of repetitive TMS is a generalized tonic-clonic seizure [<a href="#rid22">22,57,58</a>]. However, seizures are rarely observed and the risk appears to be comparable to that for antidepressant medications. Seizures probably occur in less than 0.1 to 0.5 percent of patients when safety guidelines regarding patient selection and stimulation parameters are followed, and one review found that the incidence of seizure was 0.003 percent [<a href="#rid16">16,22,24,57</a>]. Seizures that have occurred were self-limited, required no medications, and did not recur [<a href="#rid22">22,57,58</a>].</p><p>Factors that increase the risk of seizures include:</p><p class="bulletIndent1"><span class="glyph">●</span>Patient factors:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Personal and family (parent, sibling, or child) history of epilepsy</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Preexisting neurologic disorder (eg, prior head injury with loss of consciousness, prior brain surgery, or congenital brain malformation)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Medications that lower seizure threshold (eg, <a class="drug drug_general" data-topicid="9171" href="/z/d/drug information/9171.html" rel="external">bupropion</a>, stimulants, tricyclic antidepressants, antipsychotics, and <a class="drug drug_general" data-topicid="10281" href="/z/d/drug information/10281.html" rel="external">theophylline</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Recent discontinuation of alcohol, benzodiazepines, or anticonvulsants</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Sleep deprivation</p><p></p><p>(See  <a class="medical medical_review" href="/z/d/html/113603.html" rel="external">"Unipolar major depression: Administering transcranial magnetic stimulation (TMS)", section on 'Pretreatment assessment'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>Repetitive TMS stimulation parameters:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Higher frequency</p><p class="bulletIndent2"><span class="glyph">•</span>Increased intensity</p><p class="bulletIndent2"><span class="glyph">•</span>Shorter intertrain interval</p><p></p><p class="bulletIndent1">Excessive stimulation intensity can occur if clinicians initially fail to identify the optimal site for motor response and thus incorrectly determine that the resting motor threshold is higher than the true value [<a href="#rid16">16</a>]. During the TMS session, monitoring the contralateral hand for movement or twitching can signal the possibility of a seizure and the need to adjust treatment parameters. TMS stimulation parameters are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/113603.html" rel="external">"Unipolar major depression: Administering transcranial magnetic stimulation (TMS)", section on 'Treatment parameters'</a>.)</p><p></p><p>If a seizure occurs [<a href="#rid16">16</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Immediately terminate the procedure</p><p class="bulletIndent1"><span class="glyph">●</span>Assess airway breathing and circulation</p><p class="bulletIndent1"><span class="glyph">●</span>Do not restrain the patient or place anything in the patient’s mouth</p><p class="bulletIndent1"><span class="glyph">●</span>After convulsions cease, turn the patient onto one side to help clear the airway and prevent aspiration</p><p class="bulletIndent1"><span class="glyph">●</span>Summon emergency medical services</p><p class="bulletIndent1"><span class="glyph">●</span>Document the event, including ictal behaviors, duration, and postictal features</p><p></p><p>Most seizures remit spontaneously within two minutes. (See  <a class="medical medical_review" href="/z/d/html/2219.html" rel="external">"Evaluation and management of the first seizure in adults", section on 'Early postseizure management'</a>.)</p><p class="headingAnchor" id="H950443032"><span class="h2">Other side effects</span><span class="headingEndMark"> — </span>Hypomania and mania have been described in randomized trials [<a href="#rid124">124</a>] as well as case reports of patients with unipolar or bipolar major depression who were treated with different types of repetitive TMS [<a href="#rid125">125-134</a>]. However, the clinical significance is not known because patients with bipolar major depression can switch to mood elevated states in the absence of an antidepressant treatment. A review pooled results from 10 randomized trials (520 patients with major depression) that addressed switching to mania and found that treatment emergent mania was comparable for active TMS and sham treatment (0.8 and 0.7 percent) [<a href="#rid124">124</a>].</p><p>Treatment of unipolar major depression with repetitive TMS does not appear to increase suicidal ideation or behavior [<a href="#rid20">20</a>]. In a randomized trial that compared active TMS with sham treatment in 323 patients with unipolar major depression, there were no completed suicides and self-harm occurred in one patient in the sham group [<a href="#rid56">56</a>]. In addition, increased suicidal ideation occurred in 10 patients who received sham treatment and 1 patient in the active treatment group.</p><p>Common side effects of repetitive TMS include [<a href="#rid57">57,58</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Headache and scalp pain – Headache and scalp pain can occur proximal to the site of stimulation. A review of randomized trials in patients with major depression found that the incidence of headache with active treatment and sham treatment was 28 and 16 percent, and the incidence of scalp pain with active and sham treatment was 39 and 15 percent [<a href="#rid57">57</a>]. No migraine headaches have been reported [<a href="#rid16">16</a>].</p><p></p><p class="bulletIndent1">Headache and scalp pain may be more pronounced when higher stimulation frequencies and intensities are used; topical <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> may reduce scalp pain [<a href="#rid135">135</a>]. Reducing stimulation intensity can also decrease discomfort, but this can reduce efficacy as well [<a href="#rid16">16,105</a>]; thus, for sensitive patients, the dose of TMS can be titrated up during the first week [<a href="#rid22">22</a>]. Headache and scalp pain generally resolve over the first two weeks, although some patients may require an analgesic (eg, <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">acetaminophen</a> or <a class="drug drug_general" data-topicid="8547" href="/z/d/drug information/8547.html" rel="external">ibuprofen</a>) [<a href="#rid16">16,22</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Transient (&lt;4 hours) increase in auditory threshold – Caused by repeated clicks that are produced as current passes through the stimulating magnetic coil and mechanically deforms it; hearing loss is prevented with foam earplugs or noise protection ear coverings [<a href="#rid22">22</a>].</p><p></p><p>Another potential side effect is vasovagal syncope; management generally consists of reassurance [<a href="#rid16">16,22</a>]. In addition, encourage adequate hydration, assess concurrent pharmacotherapy for potential source of orthostasis, and check blood pressure before and after each TMS session. If syncope occurs during a session, terminate it and lower the patient’s head to promote cerebral perfusion.</p><p>Tolerability of repetitive TMS may be better with lower stimulation parameters compared with higher parameters [<a href="#rid20">20,136</a>]. (See  <a class="medical medical_review" href="/z/d/html/113603.html" rel="external">"Unipolar major depression: Administering transcranial magnetic stimulation (TMS)", section on 'Treatment parameters'</a>.)</p><p>Repetitive TMS in patients with major depression does not impair cognition [<a href="#rid20">20,56-58,137-140</a>]. Although many uncontrolled studies suggest that neuropsychological functioning may possibly improve during a course of treatment, randomized trials indicate that improvement of cognitive functioning does not differ significantly between active and sham treatment [<a href="#rid58">58,140</a>].</p><p>It is not known whether clinicians who administer repetitive TMS for years face any safety issues or long-term adverse effects [<a href="#rid57">57</a>].</p><p class="headingAnchor" id="H31837812"><span class="h1">SPECIAL POPULATIONS</span></p><p class="headingAnchor" id="H31837820"><span class="h2">Older adult</span><span class="headingEndMark"> — </span>For older adult patients with major depression, repetitive transcranial magnetic stimulation (TMS) can be beneficial if the stimulation intensity is sufficient [<a href="#rid24">24</a>]. Prefrontal atrophy in older patients can increase the distance between the coil and cortex to the point that lower intensity stimulation (which typically penetrates to a depth of 2 to 3 cm) does not affect cortical activity [<a href="#rid141">141-143</a>]; increasing the intensity above the motor threshold can overcome the added distance [<a href="#rid24">24</a>].</p><p>Evidence supporting the use of TMS for late-life depression includes randomized trials employing increased stimulation intensity as noted above:</p><p class="bulletIndent1"><span class="glyph">●</span>One trial compared high frequency, surface cortical TMS with sham treatment in 62 patients (age ≥50 years) with vascular depression (ie, late-life depression accompanied by clinical evidence of cerebrovascular disease); active TMS used an intensity set at 110 percent of the motor threshold [<a href="#rid144">144</a>]. Remission occurred in more patients treated with active TMS than sham TMS (27 versus 4 percent). However, headache occurred in twice as many patients who received active treatment (21 versus 10 percent).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A trial of deep TMS in 52 patients (age 60 to 80 years) used an intensity of 120 percent of motor threshold and found that remission occurred in more patients who received active TMS than sham TMS (40 versus 15 percent) [<a href="#rid145">145</a>]. However, pain at the stimulation site occurred in more patients treated with active TMS (16 versus 0 percent).</p><p></p><p>Across both trials, improvement of cognitive functioning was generally comparable in patients treated with active TMS and sham TMS.</p><p>The clinical features and treatment of late life depression are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1719.html" rel="external">"Diagnosis and management of late-life unipolar depression"</a>.)</p><p class="headingAnchor" id="H1182868400"><span class="h2">Poststroke depression</span><span class="headingEndMark"> — </span>Depression frequently occurs after stroke, and repetitive TMS may help these patients. As an example:</p><p class="bulletIndent1"><span class="glyph">●</span>A meta-analysis of 22 randomized trials compared TMS with no TMS in patients with poststroke depression (n &gt;1700) [<a href="#rid146">146</a>]. Nearly all the studies administered active TMS as an adjunctive treatment with usual care (eg, antidepressants), and most studies did not use sham TMS as part of the control intervention. Improvement of depression was greater with active TMS, and response (reduction of baseline symptoms ≥50 percent) occurred in more patients treated with active TMS than controls (64 versus 40 percent). In addition, improvement of neurologic function and activities of daily living were each superior in patients treated with active TMS, and discontinuation of treatment due to adverse effects was comparable for patients treated with active TMS, compared with patients who were not. However, heterogeneity across studies was substantial.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A subsequent meta-analysis of 17 randomized trials compared TMS with no TMS in patients with poststroke depression (n &gt;1000) [<a href="#rid147">147</a>]. Nearly all the studies administered active TMS as an adjunctive treatment with usual care (eg, antidepressants) and most studies did not use sham TMS as part of the control intervention. Improvement was greater with active TMS and response occurred in more patients treated with active TMS than controls (58 versus 34 percent). In addition, improvement of neurologic function and activities of daily living were each superior in patients treated with active TMS. However, heterogeneity across studies was substantial and headache was more likely to occur in patients who received active TMS (odds ratio, 3.5, 95% CI1.9-8.6).</p><p></p><p>The clinical features and treatment of poststroke depression are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1093.html" rel="external">"Complications of stroke: An overview", section on 'Depression'</a>.)</p><p class="headingAnchor" id="H193204913"><span class="h2">Pediatric depression</span><span class="headingEndMark"> — </span>Although no randomized trials have evaluated repetitive TMS for youth with treatment-resistant major depression, perhaps due to the risk of seizures, observational studies suggest that TMS may perhaps be beneficial [<a href="#rid148">148</a>]. As an example, one review identified 15 observational studies in which a total of 87 adolescents (no children) were treated with TMS [<a href="#rid149">149</a>]. Response occurred in 63 percent, generally within two to eight weeks of starting TMS. However, residual symptoms were present following treatment in many patients. In addition, many patients reported adverse effects such as headache and scalp pain, which was generally tolerated. Seizures occurred in three patients (3 percent).</p><p>The clinical features, diagnosis, and treatment of pediatric depression are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1224.html" rel="external">"Pediatric unipolar depression: Epidemiology, clinical features, assessment, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/1231.html" rel="external">"Overview of prevention and treatment for pediatric depression"</a>.)</p><p class="headingAnchor" id="H31837834"><span class="h2">Pregnancy and postpartum depression</span><span class="headingEndMark"> — </span>For pregnant and postpartum patients with major depression, small randomized trials and observational studies suggest that repetitive TMS may possibly be safe and effective [<a href="#rid150">150-157</a>]. It appears unlikely that the fetus is directly affected by repetitive TMS because magnetic fields rapidly attenuate with distance [<a href="#rid57">57</a>]. Additional information about treating antenatal depression with TMS is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1703.html" rel="external">"Severe antenatal unipolar major depression: Choosing treatment", section on 'Other options'</a>.)</p><p class="headingAnchor" id="H2332171661"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/116503.html" rel="external">"Society guideline links: Depressive disorders"</a>.)</p><p class="headingAnchor" id="H2800570"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neuromodulation procedures</strong> – Patients with unipolar major depression who do not respond to standard treatment with pharmacotherapy and psychotherapy are candidates for noninvasive neuromodulation procedures, including repetitive transcranial magnetic stimulation (TMS) and electroconvulsive therapy. (See  <a class="medical medical_review" href="/z/d/html/16519.html" rel="external">"Unipolar depression in adults: Overview of neuromodulation procedures", section on 'Noninvasive neuromodulation therapies'</a> and  <a class="medical medical_review" href="/z/d/html/1709.html" rel="external">"Overview of electroconvulsive therapy (ECT) for adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Overview of TMS</strong> – TMS modulates activity in cortical regions and associated neural circuits by passing an alternating electrical current through a metal coil placed against the scalp to generate rapidly alternating magnetic fields, which pass through the skull and induce electric currents that depolarize neurons in a focal area of the surface cortex; some TMS devices may also stimulate deeper brain structures. Standard TMS devices can administer different types of stimulation, including surface cortical stimulation, theta burst stimulation, and deep stimulation. (See <a class="local">'Overview'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Indications</strong> – TMS is indicated for patients with unipolar major depression who have failed at least one antidepressant medication, whereas TMS is contraindicated in patients with increased risks for seizures, implanted metallic hardware, cochlear implants, implanted electrical devices (eg, pacemakers, intracardiac lines, and medication pumps), and unstable general medical disorders. (See <a class="local">'Indications'</a> above and <a class="local">'Contraindications'</a> above and  <a class="medical medical_review" href="/z/d/html/14685.html" rel="external">"Unipolar depression in adults: Choosing treatment for resistant depression", section on 'Transcranial magnetic stimulation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Efficacy</strong> – For patients with treatment-resistant unipolar major depression, multiple randomized trials indicate that surface cortical TMS, theta burst TMS, and deep TMS can each be efficacious and are generally well tolerated. The most widely studied type of TMS is surface cortical TMS. Among patients who respond to acute treatment, the benefit of TMS is often stable in the short-term (eg, four weeks posttreatment) and response to TMS may persist, albeit at a lower frequency, for at least one year. However, it is not known if maintenance treatment with TMS is beneficial. (See <a class="local">'Efficacy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Safety and adverse effects</strong> – TMS is generally safe and well-tolerated. Serious adverse effects include generalized tonic-clonic seizures, but the risk is low and appears to be comparable to that for antidepressant medications. Patient factors that increase the risk of seizures include history of epilepsy; preexisting neurologic disorder; proconvulsant medications; recent discontinuation of alcohol, benzodiazepines, or anticonvulsants; and sleep deprivation. Stimulation parameters associated with seizures include higher frequency, increased intensity, and shorter intertrain interval. Common side effects include headache, scalp pain, and transient hearing loss. (See <a class="local">'Safety and adverse effects'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Special populations</strong> – For older adult patients with major depression, TMS can be beneficial if the stimulation intensity is high enough to bridge the distance between the coil and cortex. TMS may also be safe and effective for poststroke depression, as well as antenatal and postpartum major depression. The benefit of TMS for pediatric patients is not clear. (See <a class="local">'Special populations'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006; 163:1905.</a></li><li><a class="nounderline abstract_t">Holtzheimer PE, Mayberg HS. Stuck in a rut: rethinking depression and its treatment. Trends Neurosci 2011; 34:1.</a></li><li><a class="nounderline abstract_t">American Psychiatric Association. Practice Guideline for the Treatment of Patients with Major Depressive Disorder, third edition. Am J Psychiatry 2010; 167 (supplement):1.</a></li><li><a class="nounderline abstract_t">Milev RV, Giacobbe P, Kennedy SH, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation Treatments. Can J Psychiatry 2016; 61:561.</a></li><li class="breakAll">American Psychiatric Association: Practice Guideline for the Treatment of Patients with Major Depressive Disorder, Third Edition, 2010. https://psychiatryonline.org/guidelines (Accessed on November 05, 2020).</li><li><a class="nounderline abstract_t">Eranti S, Mogg A, Pluck G, et al. A randomized, controlled trial with 6-month follow-up of repetitive transcranial magnetic stimulation and electroconvulsive therapy for severe depression. Am J Psychiatry 2007; 164:73.</a></li><li><a class="nounderline abstract_t">Fitzgerald PB. Repetitive transcranial magnetic stimulation is not as effective as electroconvulsive therapy for major depression. Evid Based Ment Health 2007; 10:78.</a></li><li><a class="nounderline abstract_t">George MS. Whither TMS: A One-Trick Pony or the Beginning of a Neuroscientific Revolution? Am J Psychiatry 2019; 176:904.</a></li><li><a class="nounderline abstract_t">Selingardi PML, de Lima Rodrigues AL, da Silva VA, et al. Long-term deep-TMS does not negatively affect cognitive functions in stroke and spinal cord injury patients with central neuropathic pain. BMC Neurol 2019; 19:319.</a></li><li><a class="nounderline abstract_t">Cohen OS, Rigbi A, Yahalom G, et al. Repetitive Deep TMS for Parkinson Disease: A 3-Month Double-Blind, Randomized Sham-Controlled Study. J Clin Neurophysiol 2018; 35:159.</a></li><li><a class="nounderline abstract_t">Shimizu T, Hosomi K, Maruo T, et al. Efficacy of deep rTMS for neuropathic pain in the lower limb: a randomized, double-blind crossover trial of an H-coil and figure-8 coil. J Neurosurg 2017; 127:1172.</a></li><li><a class="nounderline abstract_t">Schwippel T, Schroeder PA, Fallgatter AJ, Plewnia C. Clinical review: The therapeutic use of theta-burst stimulation in mental disorders and tinnitus. Prog Neuropsychopharmacol Biol Psychiatry 2019; 92:285.</a></li><li><a class="nounderline abstract_t">Hensel L, Grefkes C, Tscherpel C, et al. Intermittent theta burst stimulation applied during early rehabilitation after stroke: study protocol for a randomised controlled trial. BMJ Open 2019; 9:e034088.</a></li><li><a class="nounderline abstract_t">Gaertner M, Kong JT, Scherrer KH, et al. Advancing Transcranial Magnetic Stimulation Methods for Complex Regional Pain Syndrome: An Open-Label Study of Paired Theta Burst and High-Frequency Stimulation. Neuromodulation 2018; 21:409.</a></li><li><a class="nounderline abstract_t">Carmi L, Alyagon U, Barnea-Ygael N, et al. Clinical and electrophysiological outcomes of deep TMS over the medial prefrontal and anterior cingulate cortices in OCD patients. Brain Stimul 2018; 11:158.</a></li><li><a class="nounderline abstract_t">McClintock SM, Reti IM, Carpenter LL, et al. Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression. J Clin Psychiatry 2018; 79.</a></li><li><a class="nounderline abstract_t">Dinur-Klein L, Dannon P, Hadar A, et al. Smoking cessation induced by deep repetitive transcranial magnetic stimulation of the prefrontal and insular cortices: a prospective, randomized controlled trial. Biol Psychiatry 2014; 76:742.</a></li><li><a class="nounderline abstract_t">Kozel FA, Motes MA, Didehbani N, et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: A randomized clinical trial. J Affect Disord 2018; 229:506.</a></li><li><a class="nounderline abstract_t">Kozel FA. Clinical Repetitive Transcranial Magnetic Stimulation for Posttraumatic Stress Disorder, Generalized Anxiety Disorder, and Bipolar Disorder. Psychiatr Clin North Am 2018; 41:433.</a></li><li><a class="nounderline abstract_t">George MS, Lisanby SH, Avery D, et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry 2010; 67:507.</a></li><li><a class="nounderline abstract_t">Allan C, Kalu UG, Sexton CE, Ebmeier KP. Transcranial stimulation in depression. Br J Psychiatry 2012; 200:10.</a></li><li><a class="nounderline abstract_t">Perera T, George MS, Grammer G, et al. The Clinical TMS Society Consensus Review and Treatment Recommendations for TMS Therapy for Major Depressive Disorder. Brain Stimul 2016; 9:336.</a></li><li><a class="nounderline abstract_t">Lefaucheur JP, André-Obadia N, Antal A, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin Neurophysiol 2014; 125:2150.</a></li><li><a class="nounderline abstract_t">George MS, Post RM. Daily left prefrontal repetitive transcranial magnetic stimulation for acute treatment of medication-resistant depression. Am J Psychiatry 2011; 168:356.</a></li><li><a class="nounderline abstract_t">Casarotto S, Canali P, Rosanova M, et al. Assessing the effects of electroconvulsive therapy on cortical excitability by means of transcranial magnetic stimulation and electroencephalography. Brain Topogr 2013; 26:326.</a></li><li><a class="nounderline abstract_t">Benussi A, Di Lorenzo F, Dell'Era V, et al. Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia. Neurology 2017; 89:665.</a></li><li><a class="nounderline abstract_t">Mayberg HS. Defining Neurocircuits in Depression: Insights from functional neuroimaging studies of diverse treatments. Psychiatric Annals 2006; 36:258.</a></li><li><a class="nounderline abstract_t">Baeken C, De Raedt R. Neurobiological mechanisms of repetitive transcranial magnetic stimulation on the underlying neurocircuitry in unipolar depression. Dialogues Clin Neurosci 2011; 13:139.</a></li><li><a class="nounderline abstract_t">Kito S, Fujita K, Koga Y. Regional cerebral blood flow changes after low-frequency transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in treatment-resistant depression. Neuropsychobiology 2008; 58:29.</a></li><li><a class="nounderline abstract_t">Strafella AP, Paus T, Barrett J, Dagher A. Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. J Neurosci 2001; 21:RC157.</a></li><li><a class="nounderline abstract_t">Baeken C, De Raedt R, Van Hove C, et al. HF-rTMS treatment in medication-resistant melancholic depression: results from 18FDG-PET brain imaging. CNS Spectr 2009; 14:439.</a></li><li><a class="nounderline abstract_t">Li CT, Wang SJ, Hirvonen J, et al. Antidepressant mechanism of add-on repetitive transcranial magnetic stimulation in medication-resistant depression using cerebral glucose metabolism. J Affect Disord 2010; 127:219.</a></li><li><a class="nounderline abstract_t">Luborzewski A, Schubert F, Seifert F, et al. Metabolic alterations in the dorsolateral prefrontal cortex after treatment with high-frequency repetitive transcranial magnetic stimulation in patients with unipolar major depression. J Psychiatr Res 2007; 41:606.</a></li><li><a class="nounderline abstract_t">Fitzgerald PB, Sritharan A, Daskalakis ZJ, et al. A functional magnetic resonance imaging study of the effects of low frequency right prefrontal transcranial magnetic stimulation in depression. J Clin Psychopharmacol 2007; 27:488.</a></li><li><a class="nounderline abstract_t">Fregni F, Ono CR, Santos CM, et al. Effects of antidepressant treatment with rTMS and fluoxetine on brain perfusion in PD. Neurology 2006; 66:1629.</a></li><li><a class="nounderline abstract_t">Michael N, Gösling M, Reutemann M, et al. Metabolic changes after repetitive transcranial magnetic stimulation (rTMS) of the left prefrontal cortex: a sham-controlled proton magnetic resonance spectroscopy (1H MRS) study of healthy brain. Eur J Neurosci 2003; 17:2462.</a></li><li><a class="nounderline abstract_t">Nadeau SE, McCoy KJ, Crucian GP, et al. Cerebral blood flow changes in depressed patients after treatment with repetitive transcranial magnetic stimulation: evidence of individual variability. Neuropsychiatry Neuropsychol Behav Neurol 2002; 15:159.</a></li><li><a class="nounderline abstract_t">Conca A, Fritzsche H, Peschina W, et al. Preliminary findings of simultaneous 18F-FDG and 99mTc-HMPAO SPECT in patients with depressive disorders at rest: differential correlates with ratings of anxiety. Psychiatry Res 2000; 98:43.</a></li><li><a class="nounderline abstract_t">Loo CK, Sachdev PS, Haindl W, et al. High (15 Hz) and low (1 Hz) frequency transcranial magnetic stimulation have different acute effects on regional cerebral blood flow in depressed patients. Psychol Med 2003; 33:997.</a></li><li><a class="nounderline abstract_t">Speer AM, Kimbrell TA, Wassermann EM, et al. Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biol Psychiatry 2000; 48:1133.</a></li><li><a class="nounderline abstract_t">Mayberg HS. Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull 2003; 65:193.</a></li><li><a class="nounderline abstract_t">Noda Y, Silverstein WK, Barr MS, et al. Neurobiological mechanisms of repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex in depression: a systematic review. Psychol Med 2015; 45:3411.</a></li><li><a class="nounderline abstract_t">Philip NS, Barredo J, van 't Wout-Frank M, et al. Network Mechanisms of Clinical Response to Transcranial Magnetic Stimulation in Posttraumatic Stress Disorder and Major Depressive Disorder. Biol Psychiatry 2018; 83:263.</a></li><li><a class="nounderline abstract_t">Philip NS, Barredo J, Aiken E, Carpenter LL. Neuroimaging Mechanisms of Therapeutic Transcranial Magnetic Stimulation for Major Depressive Disorder. Biol Psychiatry Cogn Neurosci Neuroimaging 2018; 3:211.</a></li><li><a class="nounderline abstract_t">Tik M, Hoffmann A, Sladky R, et al. Towards understanding rTMS mechanism of action: Stimulation of the DLPFC causes network-specific increase in functional connectivity. Neuroimage 2017; 162:289.</a></li><li><a class="nounderline abstract_t">Singh A, Erwin-Grabner T, Sutcliffe G, et al. Default mode network alterations after intermittent theta burst stimulation in healthy subjects. Transl Psychiatry 2020; 10:75.</a></li><li><a class="nounderline abstract_t">Furtado CP, Hoy KE, Maller JJ, et al. An investigation of medial temporal lobe changes and cognition following antidepressant response: a prospective rTMS study. Brain Stimul 2013; 6:346.</a></li><li><a class="nounderline abstract_t">Hayasaka S, Nakamura M, Noda Y, et al. Lateralized hippocampal volume increase following high-frequency left prefrontal repetitive transcranial magnetic stimulation in patients with major depression. Psychiatry Clin Neurosci 2017; 71:747.</a></li><li><a class="nounderline abstract_t">Garnaat SL, Yuan S, Wang H, et al. Updates on Transcranial Magnetic Stimulation Therapy for Major Depressive Disorder. Psychiatr Clin North Am 2018; 41:419.</a></li><li><a class="nounderline abstract_t">Shinba T, Kariya N, Matsuda S, et al. Increase of frontal cerebral blood volume during transcranial magnetic stimulation in depression is related to treatment effectiveness: A pilot study with near-infrared spectroscopy. Psychiatry Clin Neurosci 2018; 72:602.</a></li><li><a class="nounderline abstract_t">Avery DH, Isenberg KE, Sampson SM, et al. Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial. J Clin Psychiatry 2008; 69:441.</a></li><li><a class="nounderline abstract_t">Cleare A, Pariante CM, Young AH, et al. Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines. J Psychopharmacol 2015; 29:459.</a></li><li><a class="nounderline abstract_t">Malhi GS, Bassett D, Boyce P, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry 2015; 49:1087.</a></li><li><a class="nounderline abstract_t">Kiebs M, Hurlemann R, Mutz J. Repetitive transcranial magnetic stimulation in non-treatment-resistant depression. Br J Psychiatry 2019; 215:445.</a></li><li><a class="nounderline abstract_t">Rossi S, Hallett M, Rossini PM, Pascual-Leone A. Screening questionnaire before TMS: an update. Clin Neurophysiol 2011; 122:1686.</a></li><li><a class="nounderline abstract_t">O'Reardon JP, Solvason HB, Janicak PG, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry 2007; 62:1208.</a></li><li><a class="nounderline abstract_t">Rossi S, Hallett M, Rossini PM, et al. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol 2009; 120:2008.</a></li><li><a class="nounderline abstract_t">Loo CK, McFarquhar TF, Mitchell PB. A review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depression. Int J Neuropsychopharmacol 2008; 11:131.</a></li><li><a class="nounderline abstract_t">Connolly KR, Helmer A, Cristancho MA, et al. Effectiveness of transcranial magnetic stimulation in clinical practice post-FDA approval in the United States: results observed with the first 100 consecutive cases of depression at an academic medical center. J Clin Psychiatry 2012; 73:e567.</a></li><li><a class="nounderline abstract_t">Philip NS, Carpenter SL, Carpenter LL. Safe use of repetitive transcranial magnetic stimulation in patients with implanted vagus nerve stimulators. Brain Stimul 2014; 7:608.</a></li><li><a class="nounderline abstract_t">Ray S, Nizamie SH, Akhtar S, et al. Efficacy of adjunctive high frequency repetitive transcranial magnetic stimulation of left prefrontal cortex in depression: a randomized sham controlled study. J Affect Disord 2011; 128:153.</a></li><li><a class="nounderline abstract_t">Pallanti S, Bernardi S, Di Rollo A, et al. Unilateral low frequency versus sequential bilateral repetitive transcranial magnetic stimulation: is simpler better for treatment of resistant depression? Neuroscience 2010; 167:323.</a></li><li><a class="nounderline abstract_t">Rumi DO, Gattaz WF, Rigonatti SP, et al. Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study. Biol Psychiatry 2005; 57:162.</a></li><li><a class="nounderline abstract_t">Grunhaus L, Schreiber S, Dolberg OT, et al. A randomized controlled comparison of electroconvulsive therapy and repetitive transcranial magnetic stimulation in severe and resistant nonpsychotic major depression. Biol Psychiatry 2003; 53:324.</a></li><li><a class="nounderline abstract_t">Hausmann A, Kemmler G, Walpoth M, et al. No benefit derived from repetitive transcranial magnetic stimulation in depression: a prospective, single centre, randomised, double blind, sham controlled "add on" trial. J Neurol Neurosurg Psychiatry 2004; 75:320.</a></li><li><a class="nounderline abstract_t">Huang ML, Luo BY, Hu JB, et al. Repetitive transcranial magnetic stimulation in combination with citalopram in young patients with first-episode major depressive disorder: a double-blind, randomized, sham-controlled trial. Aust N Z J Psychiatry 2012; 46:257.</a></li><li><a class="nounderline abstract_t">Brunoni AR, Chaimani A, Moffa AH, et al. Repetitive Transcranial Magnetic Stimulation for the Acute Treatment of Major Depressive Episodes: A Systematic Review With Network Meta-analysis. JAMA Psychiatry 2017; 74:143.</a></li><li><a class="nounderline abstract_t">Papadimitropoulou K, Vossen C, Karabis A, et al. Comparative efficacy and tolerability of pharmacological and somatic interventions in adult patients with treatment-resistant depression: a systematic review and network meta-analysis. Curr Med Res Opin 2017; 33:701.</a></li><li><a class="nounderline abstract_t">Mutz J, Vipulananthan V, Carter B, et al. Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults: systematic review and network meta-analysis. BMJ 2019; 364:l1079.</a></li><li><a class="nounderline abstract_t">Schutter DJ. Quantitative review of the efficacy of slow-frequency magnetic brain stimulation in major depressive disorder. Psychol Med 2010; 40:1789.</a></li><li><a class="nounderline abstract_t">Berlim MT, Van den Eynde F, Jeff Daskalakis Z. Clinically meaningful efficacy and acceptability of low-frequency repetitive transcranial magnetic stimulation (rTMS) for treating primary major depression: a meta-analysis of randomized, double-blind and sham-controlled trials. Neuropsychopharmacology 2013; 38:543.</a></li><li><a class="nounderline abstract_t">Berlim MT, van den Eynde F, Tovar-Perdomo S, Daskalakis ZJ. Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials. Psychol Med 2014; 44:225.</a></li><li><a class="nounderline abstract_t">Berlim MT, Van den Eynde F, Daskalakis ZJ. A systematic review and meta-analysis on the efficacy and acceptability of bilateral repetitive transcranial magnetic stimulation (rTMS) for treating major depression. Psychol Med 2013; 43:2245.</a></li><li><a class="nounderline abstract_t">Slotema CW, Blom JD, Hoek HW, Sommer IE. Should we expand the toolbox of psychiatric treatment methods to include Repetitive Transcranial Magnetic Stimulation (rTMS)? A meta-analysis of the efficacy of rTMS in psychiatric disorders. J Clin Psychiatry 2010; 71:873.</a></li><li><a class="nounderline abstract_t">Allan CL, Herrmann LL, Ebmeier KP. Transcranial magnetic stimulation in the management of mood disorders. Neuropsychobiology 2011; 64:163.</a></li><li><a class="nounderline abstract_t">Gaynes BN, Lloyd SW, Lux L, et al. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis. J Clin Psychiatry 2014; 75:477.</a></li><li><a class="nounderline abstract_t">Health Quality Ontario. Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Ont Health Technol Assess Ser 2016; 16:1.</a></li><li><a class="nounderline abstract_t">Mutz J, Edgcumbe DR, Brunoni AR, Fu CHY. Efficacy and acceptability of non-invasive brain stimulation for the treatment of adult unipolar and bipolar depression: A systematic review and meta-analysis of randomised sham-controlled trials. Neurosci Biobehav Rev 2018; 92:291.</a></li><li><a class="nounderline abstract_t">McGirr A, Berlim MT. Clinical Usefulness of Therapeutic Neuromodulation for Major Depression: A Systematic Meta-Review of Recent Meta-Analyses. Psychiatr Clin North Am 2018; 41:485.</a></li><li><a class="nounderline abstract_t">Lam RW, Chan P, Wilkins-Ho M, Yatham LN. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and metaanalysis. Can J Psychiatry 2008; 53:621.</a></li><li><a class="nounderline abstract_t">Liu B, Zhang Y, Zhang L, Li L. Repetitive transcranial magnetic stimulation as an augmentative strategy for treatment-resistant depression, a meta-analysis of randomized, double-blind and sham-controlled study. BMC Psychiatry 2014; 14:342.</a></li><li><a class="nounderline abstract_t">Berlim MT, Van den Eynde F, Daskalakis ZJ. High-frequency repetitive transcranial magnetic stimulation accelerates and enhances the clinical response to antidepressants in major depression: a meta-analysis of randomized, double-blind, and sham-controlled trials. J Clin Psychiatry 2013; 74:e122.</a></li><li><a class="nounderline abstract_t">Poulet E, Brunelin J, Boeuve C, et al. Repetitive transcranial magnetic stimulation does not potentiate antidepressant treatment. Eur Psychiatry 2004; 19:382.</a></li><li><a class="nounderline abstract_t">Tendler A, Gersner R. Consensus Recommendations for rTMS in Depression: Not Entirely Correct! J Clin Psychiatry 2018; 79.</a></li><li><a class="nounderline abstract_t">McClintock SM, Reti IM, Carpenter LL, et al. Dr McClintock and Colleagues Reply. J Clin Psychiatry 2018; 79.</a></li><li><a class="nounderline abstract_t">Schutter DJ. Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis. Psychol Med 2009; 39:65.</a></li><li><a class="nounderline abstract_t">Chen J, Zhou C, Wu B, et al. Left versus right repetitive transcranial magnetic stimulation in treating major depression: a meta-analysis of randomised controlled trials. Psychiatry Res 2013; 210:1260.</a></li><li><a class="nounderline abstract_t">Lisanby SH, Husain MM, Rosenquist PB, et al. Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology 2009; 34:522.</a></li><li><a class="nounderline abstract_t">Kaster TS, Downar J, Vila-Rodriguez F, et al. Trajectories of Response to Dorsolateral Prefrontal rTMS in Major Depression: A THREE-D Study. Am J Psychiatry 2019; 176:367.</a></li><li><a class="nounderline abstract_t">Hunter AM, Minzenberg MJ, Cook IA, et al. Concomitant medication use and clinical outcome of repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder. Brain Behav 2019; 9:e01275.</a></li><li><a class="nounderline abstract_t">Kaster TS, Downar J, Vila-Rodriguez F, et al. Caution When Continuing Benzodiazepines During rTMS: Response to Hunter and Leuchter. Am J Psychiatry 2020; 177:172.</a></li><li><a class="nounderline abstract_t">Yesavage JA, Fairchild JK, Mi Z, et al. Effect of Repetitive Transcranial Magnetic Stimulation on Treatment-Resistant Major Depression in US Veterans: A Randomized Clinical Trial. JAMA Psychiatry 2018; 75:884.</a></li><li><a class="nounderline abstract_t">Hernandez MJ, Reljic T, Van Trees K, et al. Impact of Comorbid PTSD on Outcome of Repetitive Transcranial Magnetic Stimulation (TMS) for Veterans With Depression. J Clin Psychiatry 2020; 81.</a></li><li><a class="nounderline abstract_t">Feffer K, Lee HH, Mansouri F, et al. Early symptom improvement at 10 sessions as a predictor of rTMS treatment outcome in major depression. Brain Stimul 2018; 11:181.</a></li><li><a class="nounderline abstract_t">Ge R, Downar J, Blumberger DM, et al. Functional connectivity of the anterior cingulate cortex predicts treatment outcome for rTMS in treatment-resistant depression at 3-month follow-up. Brain Stimul 2020; 13:206.</a></li><li><a class="nounderline abstract_t">Richieri R, Verger A, Boyer L, et al. Predictive value of dorso-lateral prefrontal connectivity for rTMS response in treatment-resistant depression: A brain perfusion SPECT study. Brain Stimul 2018; 11:1093.</a></li><li><a class="nounderline abstract_t">Baeken C, Duprat R, Wu GR, et al. Subgenual Anterior Cingulate-Medial Orbitofrontal Functional Connectivity in Medication-Resistant Major Depression: A Neurobiological Marker for Accelerated Intermittent Theta Burst Stimulation Treatment? Biol Psychiatry Cogn Neurosci Neuroimaging 2017; 2:556.</a></li><li><a class="nounderline abstract_t">Weigand A, Horn A, Caballero R, et al. Prospective Validation That Subgenual Connectivity Predicts Antidepressant Efficacy of Transcranial Magnetic Stimulation Sites. Biol Psychiatry 2018; 84:28.</a></li><li><a class="nounderline abstract_t">Avissar M, Powell F, Ilieva I, et al. Functional connectivity of the left DLPFC to striatum predicts treatment response of depression to TMS. Brain Stimul 2017; 10:919.</a></li><li><a class="nounderline abstract_t">Corlier J, Wilson A, Hunter AM, et al. Changes in Functional Connectivity Predict Outcome of Repetitive Transcranial Magnetic Stimulation Treatment of Major Depressive Disorder. Cereb Cortex 2019; 29:4958.</a></li><li><a class="nounderline abstract_t">Drysdale AT, Grosenick L, Downar J, et al. Resting-state connectivity biomarkers define neurophysiological subtypes of depression. Nat Med 2017; 23:28.</a></li><li><a class="nounderline abstract_t">Silverstein WK, Noda Y, Barr MS, et al. NEUROBIOLOGICAL PREDICTORS OF RESPONSE TO DORSOLATERAL PREFRONTAL CORTEX REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION IN DEPRESSION: A SYSTEMATIC REVIEW. Depress Anxiety 2015; 32:871.</a></li><li><a class="nounderline abstract_t">Kedzior KK, Reitz SK, Azorina V, Loo C. Durability of the antidepressant effect of the high-frequency repetitive transcranial magnetic stimulation (rTMS) In the absence of maintenance treatment in major depression: a systematic review and meta-analysis of 16 double-blind, randomized, sham-controlled trials. Depress Anxiety 2015; 32:193.</a></li><li><a class="nounderline abstract_t">Senova S, Cotovio G, Pascual-Leone A, Oliveira-Maia AJ. Durability of antidepressant response to repetitive transcranial magnetic stimulation: Systematic review and meta-analysis. Brain Stimul 2019; 12:119.</a></li><li><a class="nounderline abstract_t">Fitzgerald PB, Daskalakis ZJ. A practical guide to the use of repetitive transcranial magnetic stimulation in the treatment of depression. Brain Stimul 2012; 5:287.</a></li><li><a class="nounderline abstract_t">Hadley D, Anderson BS, Borckardt JJ, et al. Safety, tolerability, and effectiveness of high doses of adjunctive daily left prefrontal repetitive transcranial magnetic stimulation for treatment-resistant depression in a clinical setting. J ECT 2011; 27:18.</a></li><li><a class="nounderline abstract_t">Demirtas-Tatlidede A, Mechanic-Hamilton D, Press DZ, et al. An open-label, prospective study of repetitive transcranial magnetic stimulation (rTMS) in the long-term treatment of refractory depression: reproducibility and duration of the antidepressant effect in medication-free patients. J Clin Psychiatry 2008; 69:930.</a></li><li><a class="nounderline abstract_t">Dunner DL, Aaronson ST, Sackeim HA, et al. A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period. J Clin Psychiatry 2014; 75:1394.</a></li><li><a class="nounderline abstract_t">Janicak PG, Nahas Z, Lisanby SH, et al. Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain Stimul 2010; 3:187.</a></li><li><a class="nounderline abstract_t">Rosenberg O, Isserles M, Levkovitz Y, et al. Effectiveness of a second deep TMS in depression: a brief report. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35:1041.</a></li><li><a class="nounderline abstract_t">Kelly MS, Oliveira-Maia AJ, Bernstein M, et al. Initial Response to Transcranial Magnetic Stimulation Treatment for Depression Predicts Subsequent Response. J Neuropsychiatry Clin Neurosci 2017; 29:179.</a></li><li><a class="nounderline abstract_t">Philip NS, Dunner DL, Dowd SM, et al. Can Medication Free, Treatment-Resistant, Depressed Patients Who Initially Respond to TMS Be Maintained Off Medications? A Prospective, 12-Month Multisite Randomized Pilot Study. Brain Stimul 2016; 9:251.</a></li><li><a class="nounderline abstract_t">Benadhira R, Thomas F, Bouaziz N, et al. A randomized, sham-controlled study of maintenance rTMS for treatment-resistant depression (TRD). Psychiatry Res 2017; 258:226.</a></li><li><a class="nounderline abstract_t">Benadhira R, Saba G, Samaan A, et al. Transcranial magnetic stimulation for refractory depression. Am J Psychiatry 2005; 162:193.</a></li><li><a class="nounderline abstract_t">Richieri R, Guedj E, Michel P, et al. Maintenance transcranial magnetic stimulation reduces depression relapse: a propensity-adjusted analysis. J Affect Disord 2013; 151:129.</a></li><li><a class="nounderline abstract_t">Fitzgerald PB, Grace N, Hoy KE, et al. An open label trial of clustered maintenance rTMS for patients with refractory depression. Brain Stimul 2013; 6:292.</a></li><li><a class="nounderline abstract_t">Wang HN, Wang XX, Zhang RG, et al. Clustered repetitive transcranial magnetic stimulation for the prevention of depressive relapse/recurrence: a randomized controlled trial. Transl Psychiatry 2017; 7:1292.</a></li><li><a class="nounderline abstract_t">Berlim MT, McGirr A, Rodrigues Dos Santos N, et al. Efficacy of theta burst stimulation (TBS) for major depression: An exploratory meta-analysis of randomized and sham-controlled trials. J Psychiatr Res 2017; 90:102.</a></li><li><a class="nounderline abstract_t">Blumberger DM, Vila-Rodriguez F, Thorpe KE, et al. Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial. Lancet 2018; 391:1683.</a></li><li><a class="nounderline abstract_t">Bersani FS, Minichino A, Enticott PG, et al. Deep transcranial magnetic stimulation as a treatment for psychiatric disorders: a comprehensive review. Eur Psychiatry 2013; 28:30.</a></li><li><a class="nounderline abstract_t">Levkovitz Y, Harel EV, Roth Y, et al. Deep transcranial magnetic stimulation over the prefrontal cortex: evaluation of antidepressant and cognitive effects in depressive patients. Brain Stimul 2009; 2:188.</a></li><li><a class="nounderline abstract_t">Levkovitz Y, Isserles M, Padberg F, et al. Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial. World Psychiatry 2015; 14:64.</a></li><li><a class="nounderline abstract_t">Filipčić I, Šimunović Filipčić I, Milovac Ž, et al. Efficacy of repetitive transcranial magnetic stimulation using a figure-8-coil or an H1-Coil in treatment of major depressive disorder; A randomized clinical trial. J Psychiatr Res 2019; 114:113.</a></li><li><a class="nounderline abstract_t">Xia G, Gajwani P, Muzina DJ, et al. Treatment-emergent mania in unipolar and bipolar depression: focus on repetitive transcranial magnetic stimulation. Int J Neuropsychopharmacol 2008; 11:119.</a></li><li><a class="nounderline abstract_t">Dolberg OT, Schreiber S, Grunhaus L. Transcranial magnetic stimulation-induced switch into mania: a report of two cases. Biol Psychiatry 2001; 49:468.</a></li><li><a class="nounderline abstract_t">Garcia-Toro M. Acute manic symptomatology during repetitive transcranial magnetic stimulation in a patient with bipolar depression. Br J Psychiatry 1999; 175:491.</a></li><li><a class="nounderline abstract_t">Nedjat S, Folkerts HW. Induction of a reversible state of hypomania by rapid-rate transcranial magnetic stimulation over the left prefrontal lobe. J ECT 1999; 15:166.</a></li><li><a class="nounderline abstract_t">Rachid F, Golaz J, Bondolfi G, Bertschy G. Induction of a mixed depressive episode during rTMS treatment in a patient with refractory major depression. World J Biol Psychiatry 2006; 7:261.</a></li><li><a class="nounderline abstract_t">Sakkas P, Mihalopoulou P, Mourtzouhou P, et al. Induction of mania by rTMS: report of two cases. Eur Psychiatry 2003; 18:196.</a></li><li><a class="nounderline abstract_t">Chang CH, Chen SJ, Chang CH, Tsai HC. Manic episode following a combined treatment of repetitive transcranial magnetic stimulation and venlafaxine. J Neuropsychiatry Clin Neurosci 2010; 22:E18.</a></li><li><a class="nounderline abstract_t">Gijsman HJ. Mania after transcranial magnetic stimulation in PTSD. Am J Psychiatry 2005; 162:398; author reply 398.</a></li><li><a class="nounderline abstract_t">Huang CC, Su TP, Shan IK. A case report of repetitive transcranial magnetic stimulation-induced mania. Bipolar Disord 2004; 6:444.</a></li><li><a class="nounderline abstract_t">Hausmann A, Kramer-Reinstadler K, Lechner-Schoner T, et al. Can bilateral prefrontal repetitive transcranial magnetic stimulation (rTMS) induce mania? A case report. J Clin Psychiatry 2004; 65:1575.</a></li><li><a class="nounderline abstract_t">Garg S, Agarwal R, Tikka SK, Khattri S. Treatment emergent affective switch with intermittent theta burst stimulation over right temporo-parietal junction: A case report. Brain Stimul 2020; 13:275.</a></li><li><a class="nounderline abstract_t">Trevino K, McClintock SM, Husain MM. The use of topical lidocaine to reduce pain during repetitive transcranial magnetic stimulation for the treatment of depression. J ECT 2011; 27:44.</a></li><li><a class="nounderline abstract_t">O'Reardon JP, Blumner KH, Peshek AD, et al. Long-term maintenance therapy for major depressive disorder with rTMS. J Clin Psychiatry 2005; 66:1524.</a></li><li><a class="nounderline abstract_t">Loo C, Sachdev P, Elsayed H, et al. Effects of a 2- to 4-week course of repetitive transcranial magnetic stimulation (rTMS) on neuropsychologic functioning, electroencephalogram, and auditory threshold in depressed patients. Biol Psychiatry 2001; 49:615.</a></li><li><a class="nounderline abstract_t">Martis B, Alam D, Dowd SM, et al. Neurocognitive effects of repetitive transcranial magnetic stimulation in severe major depression. Clin Neurophysiol 2003; 114:1125.</a></li><li><a class="nounderline abstract_t">Hausmann A, Pascual-Leone A, Kemmler G, et al. No deterioration of cognitive performance in an aggressive unilateral and bilateral antidepressant rTMS add-on trial. J Clin Psychiatry 2004; 65:772.</a></li><li><a class="nounderline abstract_t">Moreines JL, McClintock SM, Holtzheimer PE. Neuropsychologic effects of neuromodulation techniques for treatment-resistant depression: a review. Brain Stimul 2011; 4:17.</a></li><li><a class="nounderline abstract_t">Kozel FA, Nahas Z, deBrux C, et al. How coil-cortex distance relates to age, motor threshold, and antidepressant response to repetitive transcranial magnetic stimulation. J Neuropsychiatry Clin Neurosci 2000; 12:376.</a></li><li><a class="nounderline abstract_t">Nahas Z, Teneback CC, Kozel A, et al. Brain effects of TMS delivered over prefrontal cortex in depressed adults: role of stimulation frequency and coil-cortex distance. J Neuropsychiatry Clin Neurosci 2001; 13:459.</a></li><li><a class="nounderline abstract_t">Mosimann UP, Marré SC, Werlen S, et al. Antidepressant effects of repetitive transcranial magnetic stimulation in the elderly: correlation between effect size and coil-cortex distance. Arch Gen Psychiatry 2002; 59:560.</a></li><li><a class="nounderline abstract_t">Jorge RE, Moser DJ, Acion L, Robinson RG. Treatment of vascular depression using repetitive transcranial magnetic stimulation. Arch Gen Psychiatry 2008; 65:268.</a></li><li><a class="nounderline abstract_t">Kaster TS, Daskalakis ZJ, Noda Y, et al. Efficacy, tolerability, and cognitive effects of deep transcranial magnetic stimulation for late-life depression: a prospective randomized controlled trial. Neuropsychopharmacology 2018; 43:2231.</a></li><li><a class="nounderline abstract_t">Shen X, Liu M, Cheng Y, et al. Repetitive transcranial magnetic stimulation for the treatment of post-stroke depression: A systematic review and meta-analysis of randomized controlled clinical trials. J Affect Disord 2017; 211:65.</a></li><li><a class="nounderline abstract_t">Liu C, Wang M, Liang X, et al. Efficacy and Safety of High-Frequency Repetitive Transcranial Magnetic Stimulation for Poststroke Depression: A Systematic Review and Meta-analysis. Arch Phys Med Rehabil 2019; 100:1964.</a></li><li><a class="nounderline abstract_t">MacMaster FP, Croarkin PE, Wilkes TC, et al. Repetitive Transcranial Magnetic Stimulation in Youth With Treatment Resistant Major Depression. Front Psychiatry 2019; 10:170.</a></li><li><a class="nounderline abstract_t">Magavi LR, Reti IM, Vasa RA. A review of repetitive transcranial magnetic stimulation for adolescents with treatment-resistant depression. Int Rev Psychiatry 2017; :1.</a></li><li><a class="nounderline abstract_t">Cole J, Bright K, Gagnon L, McGirr A. A systematic review of the safety and effectiveness of repetitive transcranial magnetic stimulation in the treatment of peripartum depression. J Psychiatr Res 2019; 115:142.</a></li><li><a class="nounderline abstract_t">Kim DR, Wang E, McGeehan B, et al. Randomized controlled trial of transcranial magnetic stimulation in pregnant women with major depressive disorder. Brain Stimul 2019; 12:96.</a></li><li><a class="nounderline abstract_t">Kim DR, Epperson N, Paré E, et al. An open label pilot study of transcranial magnetic stimulation for pregnant women with major depressive disorder. J Womens Health (Larchmt) 2011; 20:255.</a></li><li><a class="nounderline abstract_t">Garcia KS, Flynn P, Pierce KJ, Caudle M. Repetitive transcranial magnetic stimulation treats postpartum depression. Brain Stimul 2010; 3:36.</a></li><li><a class="nounderline abstract_t">Nahas Z, Molloy MA, Hughes PL, et al. Repetitive transcranial magnetic stimulation: perspectives for application in the treatment of bipolar and unipolar disorders. Bipolar Disord 1999; 1:73.</a></li><li><a class="nounderline abstract_t">Zhang X, Liu K, Sun J, Zheng Z. Safety and feasibility of repetitive transcranial magnetic stimulation (rTMS) as a treatment for major depression during pregnancy. Arch Womens Ment Health 2010; 13:369.</a></li><li><a class="nounderline abstract_t">Klirova M, Novak T, Kopecek M, et al. Repetitive transcranial magnetic stimulation (rTMS) in major depressive episode during pregnancy. Neuro Endocrinol Lett 2008; 29:69.</a></li><li><a class="nounderline abstract_t">Felipe RM, Ferrão YA. Transcranial magnetic stimulation for treatment of major depression during pregnancy: a review. Trends Psychiatry Psychother 2016; 38:190.</a></li></ol></div><div id="topicVersionRevision">Topic 14641 Version 26.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17074942" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21067824" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Stuck in a rut: rethinking depression and its treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Practice Guideline for the Treatment of Patients with Major Depressive Disorder, third edition</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27486154" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation Treatments.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27486154" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation Treatments.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17202547" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : A randomized, controlled trial with 6-month follow-up of repetitive transcranial magnetic stimulation and electroconvulsive therapy for severe depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17652560" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Repetitive transcranial magnetic stimulation is not as effective as electroconvulsive therapy for major depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31672044" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Whither TMS: A One-Trick Pony or the Beginning of a Neuroscientific Revolution?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31823735" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Long-term deep-TMS does not negatively affect cognitive functions in stroke and spinal cord injury patients with central neuropathic pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29373395" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Repetitive Deep TMS for Parkinson Disease: A 3-Month Double-Blind, Randomized Sham-Controlled Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28156250" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Efficacy of deep rTMS for neuropathic pain in the lower limb: a randomized, double-blind crossover trial of an H-coil and figure-8 coil.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30707989" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Clinical review: The therapeutic use of theta-burst stimulation in mental disorders and tinnitus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31892668" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Intermittent theta burst stimulation applied during early rehabilitation after stroke: study protocol for a randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29504190" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Advancing Transcranial Magnetic Stimulation Methods for Complex Regional Pain Syndrome: An Open-Label Study of Paired Theta Burst and High-Frequency Stimulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28927961" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Clinical and electrophysiological outcomes of deep TMS over the medial prefrontal and anterior cingulate cortices in OCD patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28541649" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25038985" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Smoking cessation induced by deep repetitive transcranial magnetic stimulation of the prefrontal and insular cortices: a prospective, randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29351885" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: A randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30098656" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Clinical Repetitive Transcranial Magnetic Stimulation for Posttraumatic Stress Disorder, Generalized Anxiety Disorder, and Bipolar Disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20439832" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22215863" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Transcranial stimulation in depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27090022" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : The Clinical TMS Society Consensus Review and Treatment Recommendations for TMS Therapy for Major Depressive Disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25034472" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21474597" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Daily left prefrontal repetitive transcranial magnetic stimulation for acute treatment of medication-resistant depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23053600" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Assessing the effects of electroconvulsive therapy on cortical excitability by means of transcranial magnetic stimulation and electroencephalography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28747446" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Defining Neurocircuits in Depression: Insights from functional neuroimaging studies of diverse treatments</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21485753" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Neurobiological mechanisms of repetitive transcranial magnetic stimulation on the underlying neurocircuitry in unipolar depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18781088" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Regional cerebral blood flow changes after low-frequency transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in treatment-resistant depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11459878" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19890238" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : HF-rTMS treatment in medication-resistant melancholic depression: results from 18FDG-PET brain imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20598753" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Antidepressant mechanism of add-on repetitive transcranial magnetic stimulation in medication-resistant depression using cerebral glucose metabolism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16600298" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Metabolic alterations in the dorsolateral prefrontal cortex after treatment with high-frequency repetitive transcranial magnetic stimulation in patients with unipolar major depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17873682" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : A functional magnetic resonance imaging study of the effects of low frequency right prefrontal transcranial magnetic stimulation in depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16769932" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Effects of antidepressant treatment with rTMS and fluoxetine on brain perfusion in PD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12814378" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Metabolic changes after repetitive transcranial magnetic stimulation (rTMS) of the left prefrontal cortex: a sham-controlled proton magnetic resonance spectroscopy (1H MRS) study of healthy brain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12218709" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Cerebral blood flow changes in depressed patients after treatment with repetitive transcranial magnetic stimulation: evidence of individual variability.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10708925" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Preliminary findings of simultaneous 18F-FDG and 99mTc-HMPAO SPECT in patients with depressive disorders at rest: differential correlates with ratings of anxiety.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12946084" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : High (15 Hz) and low (1 Hz) frequency transcranial magnetic stimulation have different acute effects on regional cerebral blood flow in depressed patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11137053" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12697626" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26349810" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Neurobiological mechanisms of repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex in depression: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28886760" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Network Mechanisms of Clinical Response to Transcranial Magnetic Stimulation in Posttraumatic Stress Disorder and Major Depressive Disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29486862" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Neuroimaging Mechanisms of Therapeutic Transcranial Magnetic Stimulation for Major Depressive Disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28912081" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Towards understanding rTMS mechanism of action: Stimulation of the DLPFC causes network-specific increase in functional connectivity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32094326" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Default mode network alterations after intermittent theta burst stimulation in healthy subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22784443" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : An investigation of medial temporal lobe changes and cognition following antidepressant response: a prospective rTMS study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28631869" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Lateralized hippocampal volume increase following high-frequency left prefrontal repetitive transcranial magnetic stimulation in patients with major depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30098655" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Updates on Transcranial Magnetic Stimulation Therapy for Major Depressive Disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29774621" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Increase of frontal cerebral blood volume during transcranial magnetic stimulation in depression is related to treatment effectiveness: A pilot study with near-infrared spectroscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18294022" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25969470" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26643054" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31014413" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Repetitive transcranial magnetic stimulation in non-treatment-resistant depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21227747" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Screening questionnaire before TMS: an update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17573044" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19833552" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17880752" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : A review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22579164" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Effectiveness of transcranial magnetic stimulation in clinical practice post-FDA approval in the United States: results observed with the first 100 consecutive cases of depression at an academic medical center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24794163" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Safe use of repetitive transcranial magnetic stimulation in patients with implanted vagus nerve stimulators.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20621361" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Efficacy of adjunctive high frequency repetitive transcranial magnetic stimulation of left prefrontal cortex in depression: a randomized sham controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20144692" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Unilateral low frequency versus sequential bilateral repetitive transcranial magnetic stimulation: is simpler better for treatment of resistant depression?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15652875" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12586451" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : A randomized controlled comparison of electroconvulsive therapy and repetitive transcranial magnetic stimulation in severe and resistant nonpsychotic major depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14742619" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : No benefit derived from repetitive transcranial magnetic stimulation in depression: a prospective, single centre, randomised, double blind, sham controlled "add on" trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22391283" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Repetitive transcranial magnetic stimulation in combination with citalopram in young patients with first-episode major depressive disorder: a double-blind, randomized, sham-controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28030740" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Repetitive Transcranial Magnetic Stimulation for the Acute Treatment of Major Depressive Episodes: A Systematic Review With Network Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28035869" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Comparative efficacy and tolerability of pharmacological and somatic interventions in adult patients with treatment-resistant depression: a systematic review and network meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30917990" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults: systematic review and network meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20102670" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Quantitative review of the efficacy of slow-frequency magnetic brain stimulation in major depressive disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23249815" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Clinically meaningful efficacy and acceptability of low-frequency repetitive transcranial magnetic stimulation (rTMS) for treating primary major depression: a meta-analysis of randomized, double-blind and sham-controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23507264" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23200131" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : A systematic review and meta-analysis on the efficacy and acceptability of bilateral repetitive transcranial magnetic stimulation (rTMS) for treating major depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20361902" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Should we expand the toolbox of psychiatric treatment methods to include Repetitive Transcranial Magnetic Stimulation (rTMS)? A meta-analysis of the efficacy of rTMS in psychiatric disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21811086" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Transcranial magnetic stimulation in the management of mood disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24922485" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27099642" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29763711" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Efficacy and acceptability of non-invasive brain stimulation for the treatment of adult unipolar and bipolar depression: A systematic review and meta-analysis of randomised sham-controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30098660" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Clinical Usefulness of Therapeutic Neuromodulation for Major Depression: A Systematic Meta-Review of Recent Meta-Analyses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18801225" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and metaanalysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25433539" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Repetitive transcranial magnetic stimulation as an augmentative strategy for treatment-resistant depression, a meta-analysis of randomized, double-blind and sham-controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23473357" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : High-frequency repetitive transcranial magnetic stimulation accelerates and enhances the clinical response to antidepressants in major depression: a meta-analysis of randomized, double-blind, and sham-controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15363481" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Repetitive transcranial magnetic stimulation does not potentiate antidepressant treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29505181" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Consensus Recommendations for rTMS in Depression: Not Entirely Correct!</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29505184" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Dr McClintock and Colleagues Reply.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18447962" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24113125" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Left versus right repetitive transcranial magnetic stimulation in treating major depression: a meta-analysis of randomised controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18704101" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30764649" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Trajectories of Response to Dorsolateral Prefrontal rTMS in Major Depression: A THREE-D Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30941915" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Concomitant medication use and clinical outcome of repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32008395" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Caution When Continuing Benzodiazepines During rTMS: Response to Hunter and Leuchter.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29955803" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Effect of Repetitive Transcranial Magnetic Stimulation on Treatment-Resistant Major Depression in US Veterans: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32659874" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Impact of Comorbid PTSD on Outcome of Repetitive Transcranial Magnetic Stimulation (TMS) for Veterans With Depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29107623" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Early symptom improvement at 10 sessions as a predictor of rTMS treatment outcome in major depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31668646" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Functional connectivity of the anterior cingulate cortex predicts treatment outcome for rTMS in treatment-resistant depression at 3-month follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29802071" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Predictive value of dorso-lateral prefrontal connectivity for rTMS response in treatment-resistant depression: A brain perfusion SPECT study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29560909" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Subgenual Anterior Cingulate-Medial Orbitofrontal Functional Connectivity in Medication-Resistant Major Depression: A Neurobiological Marker for Accelerated Intermittent Theta Burst Stimulation Treatment?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29274805" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Prospective Validation That Subgenual Connectivity Predicts Antidepressant Efficacy of Transcranial Magnetic Stimulation Sites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28747260" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Functional connectivity of the left DLPFC to striatum predicts treatment response of depression to TMS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30953441" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Changes in Functional Connectivity Predict Outcome of Repetitive Transcranial Magnetic Stimulation Treatment of Major Depressive Disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27918562" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Resting-state connectivity biomarkers define neurophysiological subtypes of depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26382227" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : NEUROBIOLOGICAL PREDICTORS OF RESPONSE TO DORSOLATERAL PREFRONTAL CORTEX REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION IN DEPRESSION: A SYSTEMATIC REVIEW.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25683231" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Durability of the antidepressant effect of the high-frequency repetitive transcranial magnetic stimulation (rTMS) In the absence of maintenance treatment in major depression: a systematic review and meta-analysis of 16 double-blind, randomized, sham-controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30344109" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Durability of antidepressant response to repetitive transcranial magnetic stimulation: Systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22037123" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : A practical guide to the use of repetitive transcranial magnetic stimulation in the treatment of depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21343710" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Safety, tolerability, and effectiveness of high doses of adjunctive daily left prefrontal repetitive transcranial magnetic stimulation for treatment-resistant depression in a clinical setting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18505308" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : An open-label, prospective study of repetitive transcranial magnetic stimulation (rTMS) in the long-term treatment of refractory depression: reproducibility and duration of the antidepressant effect in medication-free patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25271871" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20965447" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21354242" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Effectiveness of a second deep TMS in depression: a brief report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27899052" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Initial Response to Transcranial Magnetic Stimulation Treatment for Depression Predicts Subsequent Response.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26708778" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Can Medication Free, Treatment-Resistant, Depressed Patients Who Initially Respond to TMS Be Maintained Off Medications? A Prospective, 12-Month Multisite Randomized Pilot Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28844559" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : A randomized, sham-controlled study of maintenance rTMS for treatment-resistant depression (TRD).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15625226" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Transcranial magnetic stimulation for refractory depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23790811" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Maintenance transcranial magnetic stimulation reduces depression relapse: a propensity-adjusted analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22683273" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : An open label trial of clustered maintenance rTMS for patients with refractory depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29249805" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Clustered repetitive transcranial magnetic stimulation for the prevention of depressive relapse/recurrence: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28254709" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Efficacy of theta burst stimulation (TBS) for major depression: An exploratory meta-analysis of randomized and sham-controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29726344" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22559998" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Deep transcranial magnetic stimulation as a treatment for psychiatric disorders: a comprehensive review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20633419" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Deep transcranial magnetic stimulation over the prefrontal cortex: evaluation of antidepressant and cognitive effects in depressive patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25655160" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31059991" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Efficacy of repetitive transcranial magnetic stimulation using a figure-8-coil or an H1-Coil in treatment of major depressive disorder; A randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17335643" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Treatment-emergent mania in unipolar and bipolar depression: focus on repetitive transcranial magnetic stimulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11274660" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Transcranial magnetic stimulation-induced switch into mania: a report of two cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10789285" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Acute manic symptomatology during repetitive transcranial magnetic stimulation in a patient with bipolar depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10378159" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Induction of a reversible state of hypomania by rapid-rate transcranial magnetic stimulation over the left prefrontal lobe.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17071547" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Induction of a mixed depressive episode during rTMS treatment in a patient with refractory major depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12814856" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : Induction of mania by rTMS: report of two cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20463132" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : Manic episode following a combined treatment of repetitive transcranial magnetic stimulation and venlafaxine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15677613" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : Mania after transcranial magnetic stimulation in PTSD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15383141" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : A case report of repetitive transcranial magnetic stimulation-induced mania.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15554775" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : Can bilateral prefrontal repetitive transcranial magnetic stimulation (rTMS) induce mania? A case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31653474" id="rid133" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>134 : Treatment emergent affective switch with intermittent theta burst stimulation over right temporo-parietal junction: A case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21233765" id="rid134" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>135 : The use of topical lidocaine to reduce pain during repetitive transcranial magnetic stimulation for the treatment of depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16401152" id="rid135" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>136 : Long-term maintenance therapy for major depressive disorder with rTMS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11297719" id="rid136" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>137 : Effects of a 2- to 4-week course of repetitive transcranial magnetic stimulation (rTMS) on neuropsychologic functioning, electroencephalogram, and auditory threshold in depressed patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12804681" id="rid137" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>138 : Neurocognitive effects of repetitive transcranial magnetic stimulation in severe major depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15291654" id="rid138" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>139 : No deterioration of cognitive performance in an aggressive unilateral and bilateral antidepressant rTMS add-on trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21255751" id="rid139" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>140 : Neuropsychologic effects of neuromodulation techniques for treatment-resistant depression: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10956572" id="rid140" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>141 : How coil-cortex distance relates to age, motor threshold, and antidepressant response to repetitive transcranial magnetic stimulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11748315" id="rid141" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>142 : Brain effects of TMS delivered over prefrontal cortex in depressed adults: role of stimulation frequency and coil-cortex distance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12044199" id="rid142" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>143 : Antidepressant effects of repetitive transcranial magnetic stimulation in the elderly: correlation between effect size and coil-cortex distance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18316673" id="rid143" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>144 : Treatment of vascular depression using repetitive transcranial magnetic stimulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29946106" id="rid144" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>145 : Efficacy, tolerability, and cognitive effects of deep transcranial magnetic stimulation for late-life depression: a prospective randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28092847" id="rid145" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>146 : Repetitive transcranial magnetic stimulation for the treatment of post-stroke depression: A systematic review and meta-analysis of randomized controlled clinical trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31002813" id="rid146" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>147 : Efficacy and Safety of High-Frequency Repetitive Transcranial Magnetic Stimulation for Poststroke Depression: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30984044" id="rid147" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>148 : Repetitive Transcranial Magnetic Stimulation in Youth With Treatment Resistant Major Depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28306351" id="rid148" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>149 : A review of repetitive transcranial magnetic stimulation for adolescents with treatment-resistant depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31129438" id="rid149" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>150 : A systematic review of the safety and effectiveness of repetitive transcranial magnetic stimulation in the treatment of peripartum depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30249416" id="rid150" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>151 : Randomized controlled trial of transcranial magnetic stimulation in pregnant women with major depressive disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21314450" id="rid151" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>152 : An open label pilot study of transcranial magnetic stimulation for pregnant women with major depressive disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20633429" id="rid152" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>153 : Repetitive transcranial magnetic stimulation treats postpartum depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11252662" id="rid153" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>154 : Repetitive transcranial magnetic stimulation: perspectives for application in the treatment of bipolar and unipolar disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20386939" id="rid154" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>155 : Safety and feasibility of repetitive transcranial magnetic stimulation (rTMS) as a treatment for major depression during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18283246" id="rid155" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>156 : Repetitive transcranial magnetic stimulation (rTMS) in major depressive episode during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28076639" id="rid156" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>157 : Transcranial magnetic stimulation for treatment of major depression during pregnancy: a review.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
